VNUE VNUE Inc (PK)

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 10-Q

 

☑ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the quarterly period ended September 30, 2023

 

or

 

☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

Commission File Number: 000-53462

 

VNUE, INC.

(Exact name of registrant as specified in its charter)

 

Nevada		98-0543851
(State or other jurisdiction of incorporation or organization)		(I.R.S. Employer Identification No.)

 

104 West 29th Street, 11th Floor, New York, NY 10001

(Address of Principal Executive Offices)

 

833.937.5493

(Registrant’s telephone number, including area code)

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of Each Class		Trading Symbol		Name of each Exchange on which registered
N/A		N/A		N/A

 

Securities registered pursuant to Section 12(g) of the Act: Common stock, $.0001 par value

 

Indicate by check mark if the registrant is a well-known seasoned issuer, as defined in Rule 405 of the Securities Act. Yes ☐   No ☑

 

Indicate by check mark if the registrant is not required to file reports pursuant to Section 13 or Section 15(d) of the Act. Yes ☐   No ☑

 

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☑   No ☐

 

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☑    No ☐

 

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

 

☐	Large accelerated filer	☐	Accelerated filer
☒	Non-accelerated Filer	☒	Smaller reporting company
		☐	Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

 

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Act). Yes ☐   No ☑

 

The number of shares of registrant’s common stock outstanding as of November 20, 2023 was 2,569,524,695.

 

 

 

VNUE, INC.

QUARTERLY REPORT ON FORM 10-Q

SEPTEMBER 30, 2023

 

TABLE OF CONTENTS

 

				Page
		PART I - FINANCIAL INFORMATION
Item 1.		Condensed Consolidated Financial Statements (unaudited)		1
		Condensed Consolidated Balance Sheets as of September 30, 2023 (unaudited) and December 31, 2022		1
		Condensed Consolidated Statements of Operations for the Three and Nine Months ended September 30, 2023, and 2022 (unaudited)		2
		Condensed Consolidated Statements of Changes in Stockholders’ Deficit for the Three and Nine Months ended September 30, 2023, and 2022 (unaudited)		3
		Condensed Consolidated Statements of Cash Flows for the Three and Nine Months ended September 30, 2023, and 2022 (unaudited)		5
		Notes to Condensed Consolidated Financial Statements (unaudited)		6
Item 2.		Management Discussion & Analysis of Financial Condition and Results of Operations		19
Item 3.		Quantitative and Qualitative Disclosures About Market Risk		25
Item 4.		Controls and Procedures		25
		PART II - OTHER INFORMATION
Item 1.		Legal Proceedings		27
Item 2.		Unregistered Sales of Equity Securities and Use of Proceeds		27
Item 3.		Defaults Upon Senior Securities		27
Item 4.		Mining Safety Disclosures		27
Item 5.		Other Information		27
Item 6.		Exhibits		28
		SIGNATURES		29

 

 

 

PART I - FINANCIAL INFORMATION

 

Item 1. Condensed Consolidated Financial Statements.

 

The following unaudited interim condensed consolidated financial statements of VNUE, Inc. (referred to herein as the “Company,” “we,” “us” or “our”) are included in this quarterly report on Form 10-Q:

 

VNUE, INC.

CONDENSED CONSOLIDATED BALANCE SHEETS

 

		September 30,				December 31,
		2023				2022
		(Unaudited)
Assets
Current assets:
Cash		$	28,433			$	82,807
Prepaid expenses			-				130,000
Total current assets			28,433				212,807
Fixed assets, net			-				9,134
Total assets		$	28,433			$	221,941
Liabilities and Stockholders’ Deficit
Current liabilities:
Accounts payable and accrued expenses		$	2,826,672			$	2,817,102
Shares to be issued			975,174				975,174
Accrued payroll-officers			211,438				212,250
Dividends payable			429,145				210,486
Notes payable			1,329,865				1,134,262
Deferred revenue			714,613				862,597
Convertible notes payable, net			470,714				470,714
Total current liabilities			6,957,621				6,682,586
Total liabilities			6,957,621				6,682,586
Commitments and Contingencies
Stockholders’ Deficit
Preferred A stock, par value $0.0001: 20,000,000 shares authorized; 3,200,579 and 4,250,579 issued and outstanding as of September 30, 2023 and December 31, 2022			320				425
Preferred B stock, par value $0.0001: 2,500 shares authorized; 2,504 and 2,305 issued and outstanding as of September 30, 2023 and December 31, 2022			-				-
Preferred C stock, par value $0.0001: 10,000 shares authorized; 3,000 and -0- issued and outstanding as of September 30, 2023 and December 31, 2022			-				-
Common stock, par value $0.0001, 4,000,000,000 shares authorized; 2,077,292,582 and 1,676,014,753 shares issued and outstanding, as of September 30, 2023, and December 31, 2022, respectively			207,730				167,601
Additional paid-in capital			31,013,852				30,179,731
Accumulated deficit			(38,151,090	)			(36,808,403	)
Total stockholders’ deficit			(6,929,188	)			(6,460,646	)
Total Liabilities and Stockholders’ Deficit		$	28,433			$	221,941

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 

VNUE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS

(Unaudited)

 

		For the Three Months Ended								For the Nine Months Ended
		September 30,								September 30,
		2023				2022				2023				2022
Revenues - related party		$	53,470			$	3,090			$	182,773			$	9,579
Revenue, net			143,052				96,090				245,779				224,292
Total revenue			196,522				99,180				428,552				233,871
Direct costs of revenue			143,580				72,059				292,859				224,786
Gross profit (loss)			52,942				27,121				135,693				9,085
Operating expenses:
Stock-based compensation			-				-				-				15,300,000
General and administrative expense			59,638				51,586				278,057				171,896
Payroll expenses			105,008				172,374				321,796				419,204
Professional fees			135,486				99,989				460,921				581,867
Amortization of intangible assets			-				216,667				-				541,667
Total operating expenses			300,132				540,616				1,060,774				17,014,634
Operating loss			(247,190	)			(513,495	)			(925,081	)			(17,005,549	)
Other income (expense), net
Other income
Loss on the extinguishment of debt			-								-				(154,200	)
Financing costs			(58,335	)			(98,394	)			(198,948	)			(777,299	)
Other income (expense), net			(58,335	)			(98,394	)			(198,948	)			(931,499	)
Net (loss)		$	(305,525	)		$	(611,889	)		$	(1,124,029	)		$	(17,937,048	)
Preferred B Stock dividends			(69,955	)			(62,119	)			(218,658	)			(145,103	)
Net (loss) available to common shareholders		$	(375,480	)		$	(674,008	)		$	(1,342,687	)		$	(18,082,150	)
Net loss per common share - basic and diluted		$	(0.00	)		$	(0.00	)		$	(0.00	)		$	(0.01	)
Weighted average common shares outstanding:
Basic and diluted			1,991,529,123				1,491,415,223				1,853,245,752				1,459,409,678

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 

VNUE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

FOR THE THREE MONTHS AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022

(Unaudited)

 

																										Par value $0.001								Additional
		Preferred A Shares								Preferred B Shares								Preferred C Shares								Common Shares								Paid- in				Accumulated
		Number				Amount				Number				Amount				Number				Amount				Number				Amount				Capital				Deficit				Total
Balance - December 31, 2021			4,250,579			$	425				-			$	-				-			$	-				1,411,799,497			$	141,177			$	10,900,652			$	(13,835,294	)		$	(2,793,040	)
Issuance of Preferred B shares											1,500																								1,500,000								1,500,000
Financing fee paid in Pref B shares											35																								42,000								42,000
Beneficial conversion feature of Pref B shares convertible notes																																			300,000								300,000
Shares issued for services																											6,000,000				600				56,200								56,800
Shares issued upon conversion of convertible notes payable																											41,476,963				4,148				414,770								418,918
Net loss							-								-								-								-								(1,193,106	)			(1,193,106	)
Balance, March 31, 2022			4,250,579			$	425				1,535			$	-				-			$	-				1,459,276,460			$	145,925			$	13,213,622			$	(15,028,400	)		$	(1,668,428	)
Issuance of Preferred B Shares for cash											280																-				-				280,000				-				280,000
Financing fee paid in Preferred B shares											10																-				-				12,000				-				12,000
Series B dividends																																							(51,915	)			(51,915	)
Beneficial conversion feature of Preferred B shares																																			87,000								87,000
Conversion of debt to Preferred B shares											266																-				-				319,200				-				319,200
Issuance of Preferred C shares to related parties																			3,000																15,300,000								15,300,000
Acquisition shares issued for Stage It purchase																											15,229,726				1,523				152,297								153,820
Net loss							-								-								-								-								(16,163,122	)			(16,163,122	)
Balance June 30, 2022			4,250,579			$	425				2,091			$	-				3,000			$	-				1,474,506,186			$	147,448			$	29,364,119			$	(31,243,437	)		$	(1,731,445	)
Issuance of Preferred B Shares for cash											164																								151,600								151,600
Financing fee paid in Preferred B shares											12																								14,400								14,400
Shares issued pursuant to the Company’s equity line of credit																											49,451,287				4,945				119,314								124,259
Series B dividends																																							(62,119	)			(62,119	)
Beneficial conversion feature of Preferred B shares																																			45,200								45,200
Acquisition shares issued for Stage It purchase																											1,772,076				177				17,721								17,898
Net loss							-								-								-								-								(611,889	)			(611,889	)
Balance September 30, 2022			4,250,579			$	425				2,267			$	-				3,000			$	-				1,525,729,549			$	152,570			$	29,712,354			$	(31,917,445	)		$	(2,052,096	)

 

 

VNUE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS’ DEFICIT

FOR THE THREE MONTHS AND NINE MONTHS ENDED SEPTEMBER 30, 2023 AND 2022 (Continued)

(Unaudited)

 

																										Par value $0.001								Additional
		Preferred A Shares								Preferred B Shares								Preferred C Shares								Common Shares								Paid- in				Accumulated
		Number				Amount				Number				Amount				Number				Amount				Number				Amount				Capital				Deficit				Total
Balance - December 31, 2022			4,250,579			$	425				2,305			$	-				3,000			$	-				1,676,014,753			$	167,601			$	30,179,731			$	(36,808,403	)		$	(6,460,646	)
Issuance of Preferred B Shares for cash											111																								111,000								111,000
Financing fee paid in Preferred B shares											6																								6,000								6,000
Series B dividends																																							(65,596	)			(65,596	)
Shares issued from the Company’s equity line for cash																											107,494,116				10,749				247,848								258,597
Net loss							-								-								-								-								(373,404	)			(373,404	)
Balance, March 31, 2023			4,250,579			$	425				2,422			$	-				3,000			$	-				1,783,508,869			$	178,350			$	30,544,579			$	(37,247,403	)		$	(6,524,049	)
Issuance of Preferred B Shares for cash											73																								81,012								81,012
Financing fee paid in Preferred B shares											9																								9,988								9,988
Series B dividends																																							(83,107	)			(83,107	)
Shares issued from the Company’s equity line for cash																											106,968,935				10,697				246,144								256,841
Common stock issued for services																											5,000				500				18,000								18,500
Net loss							-								-								-								-								(445,100	)			(445,100	)
Balance, June 30, 2023			4,250,579			$	425				2,504			$	-				3,000			$	-				1,890,477,804			$	189,547			$	30,899,723			$	(37,775,610	)		$	(6,685,915	)
Conversion of Series A Preferred stock to common stock			(1,050,000	)			(105	)																			52,500,000				5,250				(5,145	)							-
Shares issued from the Company’s equity line for cash																											129,327,061				12,933				119,274								132,207
Series B Dividends																																							(69,955	)			(69,955	)
Net loss							-								-								-								-								(305,525	)			(305,525	)
Balance. September 30, 2023			3,200,579			$	320				2,504			$	-				3,000			$	-				2,077,292,582			$	207,730			$	31,013,852			$	(38,151,090	)		$	(6,929,188	)

 

The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 

VNUE, INC.

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(Unaudited)

 

		For the Nine Months Ended
		September 30,
		2023				2022
Cash Flows From Operating Activities:
Net (loss)		$	(1,124,029	)		$	(17,937,048	)
Adjustments to reconcile net income to net cash provided by (used for) operating activities
Depreciation			9,134				19,725
Amortization of intangible assets			-				541,667
Loss on the extinguishment of debt			-				154,200
Beneficial conversion feature of Preferred B stock			20,000				432,200
Issuance of Preferred C voting stock			-				15,300,000
Shares issued for financing costs			23,600				68,400
Shares issued for services			18,500				56,800
Changes in operating assets and liabilities
Prepaid expenses			130,000				364,336
Accounts payable and accrued interest			130,172				220,455
Deferred revenue			(147,984	)			4,122
Accrued payroll officers			(812	)			25,500
Net cash (used in) operating activities			(941,419	)			(749,643	)
Cash Flows From Investing Activities:
Purchase of fixed assets			-				(940	)
Acquisition of a business net of cash received			-				(977,761	)
Net cash (used in) investing activities			-				(978,701	)
Cash Flows From Financing Activities:
Proceeds from the Company’s equity line from the sale of common stock			647,645				-
Proceeds from the private placement of common shares			-				124,259
Payments on promissory notes			-				(255,280	)
Proceeds from the sale of Series B Preferred Stock			164,400				1,931,600
Proceeds from the issuance of promissory notes			75,000				3,000
Net cash provided by investing activities			887,045				1,803,579
Net Increase (Decrease) In Cash			(54,374	)			75,235
Cash At The Beginning Of The Period			82,807				36,958
Cash At The End Of The Period		$	28,433			$	112,193
Supplemental disclosure of non-cash information:
Common shares issued for the Stage It acquisition		$	-			$	572,738
Issuance of Preferred C voting shares		$	-			$	15,300,000
Preferred B shares issued upon the conversion of debt and accrued interest		$	-			$	176,410

 

 The accompanying notes are an integral part of these unaudited condensed consolidated financial statements.

 

 

VNUE, INC.

NOTES TO UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

 

NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION

 

History and Organization

 

VNUE, Inc. (formerly Tierra Grande Resources, Inc.) (“VNUE”, “TGRI”, or the “Company”) was incorporated under the laws of the State of Nevada on April 4, 2006.

 

On May 29, 2015, VNUE, Inc. entered into a merger agreement with VNUE Washington, Inc. Pursuant to the terms of the Merger Agreement, all of the outstanding shares of any class or series of VNUE Washington were exchanged for an aggregate of 50,762,987 shares of TGRI common stock. As a result of the Merger, VNUE Washington became a wholly-owned subsidiary of the Company, and the transaction was accounted for as a reverse merger with VNUE Washington deemed the acquiring company for accounting purposes, and the Company deemed the legal acquirer.

 

The Company is developing technology-driven solutions for Artists, Venues, and Festivals to automate the capturing, publishing, and monetization of their content, as well as protection of their rights.

 

On February 13, 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company will acquire Stage It for up to $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly-owned subsidiary of the Company (the “Merger”).

 

On February 13, 2022, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company contracted to acquire Stage It for up to $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly-owned subsidiary of the Company (the “Merger”). At the same time, Stage It and several of the shareholders of Stage It entered into a voting agreement concerning the Merger.

 

Pursuant to the Merger Agreement, at the closing of the Merger (the “Closing”), each of Stage It’s outstanding shares (including common and preferred shares) were converted into the right to receive the applicable portion of the Merger Consideration. $1,085,450 of the Merger Consideration was paid in cash and satisfaction of certain outstanding debt obligations of Stage It, as outlined in a Closing Payment Certificate of the Merger Agreement, and the other portion was paid in shares of the Company’s common stock or preferred stock, with the actual number of such shares to be issued reduced by the cash component outlaid in the transaction. A portion of the Merger Consideration, $1 million, was held back for the purposes of satisfying certain contingent obligations of Stage It.

 

The Merger Agreement provides for the issuance of earnout shares which the company estimates will not be achieved.

 

On February 14 2022, the Company completed the acquisition of Stage It. As a result of the Closing, Stage It became a wholly-owned subsidiary of the Company. For the acquisition, the Company issued the initial 135,000,000 shares, paid certain amounts to Stage It vendors and will potentially pay additional amounts as detailed under Merger Consideration in the Merger Agreement.

 

6

 

 

NOTE 2 – GOING CONCERN

 

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying condensed consolidated financial statements as of September 30, 2023, the Company had $28,433 in cash on hand, had negative working capital of $6,929,188 and had an accumulated deficit of $38,151,090. Additionally, for the nine months ended September 30, 2023, the Company used $941,419 in cash from operating activities. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date of the condensed consolidated financial statements being issued. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The Company does not have any commitments for additional capital.

 

The condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s September 30, 2023, condensed consolidated financial statements, has raised substantial doubt about the Company’s ability to continue as a going concern.

 

The continuation of the Company as a going concern is dependent upon its ability to obtain necessary debt or equity financing to continue operations until it begins generating positive cash flow. Historically, the Company has been able to fund its operations from the proceeds of notes payable and convertible notes. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company can obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in the case of equity financing.

 

NOTE 3 – SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES

 

Basis of Consolidation

 

The accompanying condensed consolidated financial statements have been prepared in accordance with the Financial Accounting Standards Board (“FASB”) “FASB Accounting Standard Codification™” (the “Codification”), which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of condensed consolidated financial statements in conformity with generally accepted accounting principles (“GAAP”) in the United States.

 

The Company consolidates its results with its wholly-owned subsidiary, Stage It Corp.

 

Revenue Recognition

 

The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.

 

Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed, the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer; however, there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as an agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production.

 

7

 

 

The Company also recognizes revenue from the sale of CDs and USB drives that contain the recording of live concerts and are made available to concert attendees immediately after the show and online. Revenue is recognized on the sale of a product when our performance obligation is completed, which is when the risk of loss transfers to our customers and the collection of the receivable is reasonably assured, which generally occurs when the product is purchased.

 

As of September 30, 2023 deferred revenue amounted to $714,613. As of September 30, 2023, deferred revenue was comprised of unredeemed notes at Stage It that have been purchased by customers but not used toward any events. When these notes are redeemed, on average, the performing artists will receive approximately 80%, and the Company will record 20% of the value of these notes as revenue.

 

Use of Estimates

 

The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates.

 

Stock Purchase Warrants

 

The Company accounts for warrants issued to purchase shares of its common stock as equity in accordance with FASB ASC 480, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock, Distinguishing Liabilities from Equity.

 

Fair Value of Financial Instruments

 

The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value:

 

	●	Level 1 — Quoted prices in active markets for identical assets or liabilities.
	●	Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.
	●	Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.

 

The carrying amounts of financial instruments, such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.

 

8

 

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. There were no derivative liabilities outstanding as of September 30, 2023 and December 31, 2022.

 

Income (Loss) per Common Share

 

Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that is then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on September 30, 2023, because their impact would have been anti-dilutive.

 

Property and Equipment

 

Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The carrying amount and accumulated depreciation of assets sold or retired are removed from the accounts in the year of disposal and any resulting gain or loss is included in the results of operations. The estimated useful lives of property and equipment are as follows:

 

Schedule of property plant equipment estimated useful lives
Computers, software, and office equipment		3 years
Furniture and fixtures		7 years

 

As of September 30, 2023, the Company’s property was fully depreciated. Depreciation expense for the nine months ended September 30, 2023, and 2022, amounted to $9,134 and $19,725, respectively.

 

Goodwill and Intangible Assets

 

Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. The goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets consist primarily of customer relationships, trademarks, and product formulations. The useful life of these customer relationships is estimated to be three years.

 

9

 

 

Goodwill is not amortized but is subject to annual impairment testing unless circumstances dictate more frequent assessments. The Company performs an annual impairment assessment for goodwill during the fourth quarter of each year and more frequently whenever events or changes in circumstances indicate that the fair value of the asset may be less than the carrying amount. Goodwill impairment testing compares the fair value of the reporting unit to its carrying amount. The fair value of the reporting unit is determined by considering both the income approach and market approaches. The fair values calculated under the income approach and market approaches are weighted based on circumstances surrounding the reporting unit. Under the income approach, the Company determines fair value based on estimated future cash flows of the reporting unit, which are discounted to the present value using discount factors that consider the timing and risk of cash flows. For the discount rate, the Company relies on the capital asset pricing model approach, which includes an assessment of the risk-free interest rate, the rate of return from publicly traded stocks, the Company’s risk relative to the overall market, the Company’s size and industry and other Company-specific risks. Other significant assumptions used in the income approach include the terminal value, growth rates, future capital expenditures, and changes in future working capital requirements. The market approaches use key multiples from guideline businesses that are comparable and are traded on a public market. If the fair value of the reporting unit is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess. As of December 31, 2022, the Company determined that its goodwill and intangibles were fully impaired, and as a result, recorded an impairment of goodwill and intangible assets amounting to $4,261,683 in its Statements Operations for the year ended December 31, 2022.

 

Recently Issued Accounting Pronouncements

 

In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04, and ASU 2019-05 (collectively, “Topic 326”). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. The Company will be required to adopt this ASU for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The adoption of Topic 326 is not expected to have a material effect on the Company’s condensed consolidated financial statements and financial statement disclosures.

 

NOTE 4 – PREPAID EXPENSE

 

As of September 30, 2023 and December 31, 2022, the balances in prepaid expenses was $-0- and $130,000.

 

Schedule of prepaid expense
		September 30, 2023				December 31, 2022
Matchbox Twenty (“MT”) agreement		$				$	100,000
Deposit with joint venture partner							30,000
Total prepaid expenses		$				$	130,000

 

The MT prepaid expense in both periods relates to a January 9, 2020 agreement entered into by the Company with recording and performance artist, Matchbox Twenty (“MT Agreement”), to record its 2020 tour and sell limited edition double CD sets, download cards, and digital downloads. As part of the deal, the Company agreed to pay an advance of $100,000 against sales to MT and its affiliated companies, which was paid in full in installments, with the last installment of $40,000 paid on March 4, 2020.

 

10

 

 

NOTE 5 – RELATED PARTY TRANSACTIONS

 

DiscLive Network

 

On July 10, 2017, the Company entered into a Licensing Agreement with RockHouse Live Media Productions, Inc., DBA “DiscLive” or “DiscLive Network” (“DiscLive”) to formalize the terms of the Strategic Alliance entered into by the Company with DiscLive on July 21, 2016. VNUE has acquired an exclusive license from DiscLive, for a period of three years unless earlier terminated under the Agreement, for the use of all its assets, including but not limited to the DiscLive brand, website (including eCommerce platform), intellectual property, inventory, equipment, trade secrets and anything related to its business of “instant live” recording. Under the terms of the Agreement, DiscLive granted the Company a worldwide exclusive license.

 

In exchange for the license, DiscLive will receive a license fee equal to five percent (5%) of any sales derived from the sale and use of the products and services. DiscLive is controlled by our Chief Executive Officer. Revenues of $182,773 and $9,579 for the periods ended September 30, 2023, and 2022, respectively, were recorded using the assets licensed under this agreement. For the periods ended September 30, 2023, and 2022 the fees would have amounted to $9,139 and $479, respectively. The Company’s Chief Executive Officer agreed to temporarily waive the right to receive these license fees for both years and has never taken any fees pursuant to this agreement.

 

Advances from Officers/Stockholders

 

From time to time, officers/stockholders of the Company advance funds to the Company for working capital purposes. During the year ended December 31, 2021, the Company’s Chief Executive Officer advanced $10,000 to the Company on an interest-free basis. That amount was repaid in the fourth quarter of 2022.

 

NOTE 6 – BUSINESS ACQUISITION

 

On February 13, 2022, VNUE, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company will acquire Stage It for up to $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly owned subsidiary of the Company (the “Merger”).

 

Pursuant to the Merger Agreement, and subject to the terms and conditions set forth therein, at the closing of the Merger (the “Closing”), each of Stage It’s outstanding shares (including common and preferred shares) will be converted into the right to receive the applicable portion of the Merger Consideration. A portion of the Merger Consideration will be paid in cash and take the form of satisfying certain outstanding debt obligations of Stage It, as outlined in a Closing Payment Certificate of the Merger Agreement, and the other portion will be paid in shares of the Company’s common stock or preferred stock, with the actual number of such shares to be issued reduced by the cash component outlaid in the transaction. A portion of the Merger Consideration, $1 million, will be held back to satisfy certain contingent obligations of Stage It.

 

The Merger Agreement also allows for the issuance of earn-out shares, not to exceed the overall Merger Consideration, provided that certain EBIDTA requirements are met over the course of 18 months.

 

On February 13, 2022, the Company, Stage It and the shareholders of Stage It entered into a voting agreement concerning the Merger.

 

On February 14, 2022, the Company completed the acquisition of Stage It. As a result of the Closing, Stage It became a wholly-owned subsidiary of the Company. For the acquisition, the Company will issue the initial 135,000,000 shares and pay certain amounts as detailed under Merger Consideration in the Merger Agreement. The price to be paid in cash and stock for the Earnout Shares and Holdback Shares are set forth in the Merger Agreement.

 

11

 

 

The Merger Agreement has been included to provide investors with information regarding its terms. The representations, warranties, and covenants contained in the Merger Agreement were made only for the purposes of the Merger Agreement, were made as of specific dates, were made solely for the benefit of the parties to the Merger Agreement, and may not have been intended to be statements of fact, but rather as a method of allocating risk and governing the contractual rights and relationships among the parties to the Merger Agreement. In addition, such representations, warranties, and covenants may have been qualified by certain disclosures not reflected in the text of the Merger Agreement and may apply standards of materiality and other qualifications and limitations in a way that is different from what may be viewed as material by the Company’s shareholders. None of the Company’s shareholders or any other third party should rely on the representations, warranties, and covenants, or any descriptions thereof, as characterizations of the actual state of facts or conditions of the Company, the Company, Merger Sub, or any of their respective subsidiaries or affiliates

 

For the acquisition of Stage It, the following table summarizes the acquisition date fair value of the consideration paid, identifiable assets acquired and liabilities assumed:

 

Consideration paid

 

Schedule of fair value of consideration
Common stock issued, 41,476,963 shares of the Company’s restricted common stock valued at $0.0101 per share		$	418,917
Common stock issuable, 93,523,037 shares of the Company’s restricted common stock valued at $0.0101 per share			944,583
Net liabilities assumed			2,871,066
Cash paid			1,085,450
Fair value of total consideration paid		$	5,320,016

 

Net assets acquired and liabilities assumed

 

Schedule of net asset acquired and liabilities assumed
Cash and cash equivalents		$	107,689
Computer equipment			36,882
Total assets			144,571
Accounts payable and accrued liabilities			1,711,349
Notes payable			526,385
Deferred revenue			777,903
Total liabilities			3,015,637
Net liabilities assumed		$	2,871,066

 

The Company has allocated the fair value of the total consideration paid of $10,400,000 to goodwill and $2,600,000 to intangible assets with a life of three years. The value of goodwill represents Stage It’s ability to generate profitable operations going forward. Management estimated the provisional fair values of the intangible assets and goodwill on March 31, 2022, and did not complete a valuation study with an independent third party. During the year ended December 31, 2022, the Company recorded $758,333 in amortization expense.

 

On December 31, 2022, the Company, based on its internal analysis, estimated that its Stage It subsidiary would not achieve its Earnout and that all of the goodwill and intangible assets relating to the acquisition of Stage It was fully impaired. As a result, the Company recorded an impairment of goodwill and intangible assets charge net of the earnout reversal of $4,262,683 on its Statements of Operations for the year ended December 31, 2022.

 

The amount of $4,262,683 was calculated as follows:

 

Schedule of net impairment
Goodwill impairment		$	10,400,000
Intangible assets impairment			1,542,847
Reversal of Earnout liability			(7,679,984	)
Net impairment		$	4,262,863

 

12

 

 

NOTE 7 – DEFERRED REVENUE

 

As of September 30, 2023 deferred revenue amount to $714,613 and was comprised of unredeemed notes at Stage It that have been purchased by customers but not used toward any events. When these notes are redeemed, on average, the performing artists will receive 80%, and the Company will record 20% of the value of these notes as revenue.

 

NOTE 8 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES

 

Accounts payables are recognized initially at the transaction price and subsequently measured at the undiscounted amount of cash or other consideration expected to be paid. Accrued expenses are recognized based on the expected amount required to settle the obligation or liability.

 

The following table sets forth the components of the Company’s accrued liabilities on September 30, 2023, and December 31, 2022:

 

Schedule of accrued liabilities
		September 30, 2023				December 31, 2022
Accounts payable and accrued expenses		$	2,444,903			$	2,389,231
Accrued interest			236,510				282,612
Soundstr Obligation			145,259				145,259
Total accounts payable and accrued liabilities		$	2,826,672			$	2,817,102

 

NOTE 9 – SHARES TO BE ISSUED

 

As of September 30, 2023 and December 31, 2022, the balances of shares to be issued were 975,174 and $975,174, respectively. The balance as of September 30, 2023 is comprised of the following:

 

●

As of December 31, 2022, the Company had not yet issued 5,204,352 shares of common stock with a value of $247,707 for past services provided and for an acquisition in previous years.

 

●

During the year ended December 31, 2022, pursuant to the acquisition of Stage It described throughout this Report, an additional 72,026,422 shares remain issuable to Stage It shareholders valued at $727,647.

 

NOTE 10 – NOTES PAYABLE

 

The balance of the Notes Payable outstanding as of September 30, 2023, and December 31, 2022, was $1,329,865 and $1,134,262 respectively. The balances as of September 30, 2023, were comprised of numerous 8% notes for $1,052,761 due to Ylimit, payable on September 30, 2023, and $277,104 in notes due to former Stage It shareholders. During the three months ended September 30, 2023 the company entered into a loan modification agreement with Ylimit. Under the terms of the agreement Ylimit converted $102,603 in accrued interest into loan principal, and extended the maturity date of its outstanding promissory note to September 30, 2024. Also during the three months ended September 30, 2023 Ylimit advanced $50,000 to the company. This amount is included in the outstanding balance of $1,052,761.

 

13

 

 

NOTE 11 – CONVERTIBLE NOTES PAYABLE

 

Convertible notes payable consist of the following:

 

Schedule of convertible notes payable
		September 30, 2023				December 31, 2022
Various Convertible Notes(a)		$	131,703			$	131,703
Golock Capital, LLC Convertible Notes(b)			339,011				339,011
Total Convertible Notes		$	470,714			$	470,714

 

 

(a)

This total is comprised of six convertible notes with five different noteholders. With the exception of one note for $28,500 due to a former related party which is interest free, all of the remaining notes at a 10% interest rate are past due their maturity. The Company has not received any default notices on these notes and continues to accrue interest on these notes. Additionally, $73,204 of these notes due to DBW Investments is in dispute.

(b)

On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Golock”) in the principal amount of $40,000 with an interest rate of 10% per annum and a maturity date of November 2, 2018. The note included an original issue discount of $5,000. The note is convertible into shares of the Company’s common stock at $0.015 per share. As additional consideration for Golock to enter into this agreement with the Company, the Company issued warrants to Golock to acquire in the aggregate 2,500,000 shares of the Company’s common stock at an exercise price of $0.015 per share that expire three years from the date of grant. The relative fair value of the warrants, the original issue discount, and the beneficial conversion feature totaling $40,000 was recorded as a debt discount and will be amortized to interest expense over the term of the note. On November 5, 2018, the Company amended the notes above by changing the conversion feature for the aggregate notes to be convertible into shares of common stock of the Company at the lower of (i) $0.015 per share or, (ii) 58% of the lowest closing bid price in the 20 trading days prior to the day that Golock requests conversion. This feature gave rise to a derivative liability of $553,000 at the date of issuance, as discussed below. The amendment also increased the principal face amount of notes to include accrued interest, and an additional $43,250 was added to the principal, which was recorded to financing costs. The aggregate balance of the notes outstanding, and the related debt discount was $302,067 and $0, respectively, as of December 31, 2018.

 

On April 29, 2019, Golock entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months, exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that Golock requested conversion. During the year ending December 31, 2019, the Company issued new notes payable of $53,331, and $23,102 of notes and accrued interest were converted into 100,000,000 shares of common stock. The balance of the notes outstanding on December 31, 2019 was $339,010. As of December 31, 2019, $285,679 of these notes were past due. As of September 30, 2023, all of the Golock notes amounting to $339,011 were past due.

 

As a result, Golock has assessed the Company additional penalties and interest of $1,172,782. The Company disagrees with the accrued interest and penalties due to Golock. Initially, the Company recorded this amount as a liability on its balance during 2021. Subsequently, during the three-month period ended September 30, 2021, the Company obtained a legal opinion supporting its position that these charges were egregious and reversed the liability on its balance sheet. The Company intends to litigate this amount as well as the validity of the principal and interest outstanding if a settlement on a vastly reduced amount cannot be reached.

 

14

 

 

NOTE 12 – STOCKHOLDERS’ DEFICIT

 

Common stock

 

The Company has authorized 4,000,000,000 shares of $0.0001 par value common stock. As of September 30, 2023, and December 31, 2022, there were 2,077,292,582 and 1,676,014,753 shares of common stock issued and outstanding, respectively. During the nine months ended September 30, 2023, the Company sold 343,790,112 common shares pursuant to the terms of its equity line and raised $647,645 in gross proceeds.

 

Preferred Stock Series A

 

On July 2, 2019, the Company filed a Certificate of Amendment (the “Charter Amendment”) to the Company’s Articles of Incorporation (as amended to date, the “Articles of Incorporation”) with the Secretary of State of the State of Nevada. The Charter Amendment increased the Company’s capitalization to 2,000,000,000 shares of Common Stock and 20,000,000 shares of Preferred Stock, of which 5,000,000 were designated as Series A Convertible Preferred Stock.

 

On May 22, 2019, the Company authorized and designated a class of Series A Convertible Preferred Stock (“Series A Preferred Stock”), in accordance with a Certificate of Designation filed with the State of Nevada (the “Series A Designation”). It subsequently issued 4,126,776 restricted shares of Series A Preferred Stock to various employees and service providers to compensate and reward them for services and to incentivize them to provide continued service to the Company. The Series A Preferred Stock receives relative rights and preferences under terms and conditions set forth in the Certificate of Designation of the Preferred Stock.

 

Pursuant to the Series A Designation, each share of Series A Preferred Stock may be converted into 50 shares of common stock of the Company. The Series A Preferred Stockholders shall be entitled to share among dividends with the common stock shareholders of the Company on an as-converted basis. The Series A Preferred Stockholders shall vote with the common stock as a single class, on a 100 to 1 basis, such that for every share of Series A Preferred Stock held, such shares shall entitle the holder to cast 100 votes. The holders of the Series A Preferred Stock have no liquidation or redemption preference rights but get treated as common stockholders on an as converted basis.

 

The Company believes that the issuance of the Series A Preferred Stock was exempt from the registration requirements under the Securities Act of 1933, as amended pursuant to Section 4(a)(2) of the Act in that said transaction did not involve a public solicitation and said restricted shares were issued to only a small number of employees and consultants with an ongoing relationship with the Company.

 

As of September 30, 2023 and 2022 the Company had 20,000,000 shares of $0.0001 par value preferred stock authorized and there were 3,200,579 and 4,250,579 shares of Series A Preferred Stock issued and outstanding, respectively. During the three months ended September 30, 2023 a shareholder converted 1,050,000 shares of Series A stock into 52,500,000 common shares.

 

Preferred Stock Series B (Update)

 

On January 3, 2022, the Company authorized and designated a class of 2,500 shares, par value $0.0001, of Series B Convertible Preferred Stock (“Series B Preferred Stock”), in accordance with a Certificate of Designation filed with the State of Nevada (the “Series 5 Designation”).

 

As of September 30, 2023 there were 2,504 shares of Series B Preferred Stock Outstanding.

 

During the nine months ended September 30, 2023, the Company issued 199 Preferred B shares to GHS and raised $164,000 in gross proceeds.

 

15

 

 

Warrants

 

In connection with the issuance of Series B Preferred Stock to the Company described in Note 14, the Company issued _______ warrants, with a five-year life, at an average strike price of $_________.

 

A summary of warrants is as follows:

 

Schedule of warrants
		Number of Warrants				Weighted Average Exercise
Balance outstanding, December 31, 2020			23,805,027
Warrants expired or forfeited			(8,004,708	)			-
Balance outstanding and exercisable, December 31, 2021			15,800,319
Warrants exercised or forfeited			(15,800,319	)
Warrants granted during the year ended December 31, 2022			279,655,690
Balance outstanding and exercisable, December 31, 2022			279,655,690
Warrants exercised or forfeited			-
Warrants granted during the nine months ended September 30, 2023			-
Balance outstanding and exercisable, September 30, 2023			335,440,817					(a)

 

 

(a)

The strike price on these warrants range between $0.01122 and $0.00264 and are subject to adjustment based on the market price of the Company’s stock price.

 

Information relating to outstanding warrants on September 30, 2023, summarized by exercise price, is as follows:

 

The weighted-average remaining contractual life of all warrants outstanding and exercisable on September 30, 2023 is approximately 3.75 years. As of September 30, 2023 these warrants has no intrinsic value.

 

Preferred Stock Series C

 

On May 25, 2022, the Company authorized and designated a class of 10,000 shares of Series C Preferred Stock, par value $0.0001. The holders of the Series C Preferred Stock shall have the right to cast one million (1,000,000) votes for each share held of record on all matters submitted to a vote of holders of the Company’s common stock. On the same date, the Company issued to each of Zach Bair, Chief Executive Officer & Chairman, Anthony Cardenas, Chief Financial Officer and Director, and Lou Mann, Executive Vice President and Director, 1,000 shares of this newly created Series C Preferred Stock for services rendered. These share which represented 3,000,000,000 (billion) votes, was valued at the trading price of the Company’s securities of $0.0051 on the date of Board of Director approval. As a result, the Company recorded a non-cash charge of $15,300,000 on its Statement of Operation for the three months ended September 30, 2022.

 

As of September 30, 2023 and December 31, 2022, there were 3,000 shares of Series C Preferred Stock outstanding.

 

16

 

 

NOTE 13 – COMMITMENT AND CONTINGENCIES

 

Litigation

 

Legal Matters

 

In the matter of VNUE, Inc. v. Power Up Lending Group, Ltd. On October 6, 2021, the Company commenced an action against Power Up Lending Group, Ltd. (“Power Up”) and Curt Kramer (“Kramer”) (Power Up and Kramer together, the “Power Up Parties”) in the United States District Court for the Eastern District of New York. The complaint alleges that: (1) Power Up is an unregistered dealer acting in violation of Section 15(a) of the Securities Exchange Act of 1934 (the “Act”) and, pursuant to Section 29(b) of the Act, the Company is entitled to recessionary relief from certain convertible promissory notes (“Notes”) and securities purchase agreements (“SPAs”) entered into by the Company and Power Up; (2) Kramer is liable to the Company as the control person of Power Up pursuant to Section 20(a) of the Act; and (3) Power Up is liable to the Company for unjust enrichment arising from the Notes and SPAs.

 

On December 10, 2021, the Power Up Parties filed their pre-motion conference request letter with the Court regarding their forthcoming motion to dismiss the Company’s complaint. On December 17, 2021, the Company filed its opposition thereto. On January 26, 2022, the Company filed its amended complaint, which asserted the same causes of action set forth in the initial complaint, and further alleged that Power Up made material misstatements in connection with the purchase and sale of the Company’s securities in violation of Section 10(b) of the Act and, thus, the Company is entitled to recessionary relief from the Notes and SPAs pursuant to Section 29(b) of the Act.

 

On February 9, 2022, the Court ordered an initial conference. The initial conference is currently scheduled for May 16, 2022, at 12:00 p.m. (EST). As of the date hereof, the Company intends to litigate its claims for relief against the Power Up Parties.

 

On June 7, 2022, the Company filed a voluntary dismissal of the action because the parties reached a confidential settlement.

 

Golock Capital, LLC and DBW Investments, LLC v. VNUE, Inc. On September 29, 2021, Golock Capital, LLC (“Golock”) and DBW Investments, LLC (“DBW”) (Golock and DBW together, the “Golock Plaintiffs”) commenced an action against the Company in the United States District Court for the Southern District of New York. The Golock Plaintiffs’ complaint alleges that the Company is in breach of certain convertible promissory notes and securities purchase agreements separately entered into with Golock and DBW and seeks declaratory judgment, injunctive relief, and specific performance against the Company.

 

On December 2, 2021, the Golock Plaintiffs filed their amended complaint, which asserted the same causes of action set forth in the initial complaint and an additional cause of action for unjust enrichment. On January 19, 2022, the Company filed its answer with affirmative defenses to the amended complaint. As to its affirmative defenses, the Company asserted that the Golock Plaintiff’s claims are barred because: (1) the Golock Plaintiffs are unregistered dealers acting in violation of Section 15(a) of the Securities Exchange Act of 1934 (the “Act”), and, pursuant to Section 29(b) of the Act, that the Company is entitled to recessionary relief from the certain convertible promissory notes and securities purchase agreements at issue in the amended complaint; and (2) that the convertible promissory notes are, in fact, criminally usurious loans that impose interest onto the Company at a rate that violates New York Penal Law § 190.40 and, therefore, the subject convertible notes are void ab initio pursuant to New York’s usury laws.

 

On January 20, 2022, the Court ordered that the parties submit a joint letter in lieu of a pretrial conference on or before February 3, 2022. As of the date hereof, the Company intends to vigorously defend itself against the Golock Plaintiff’s claims.

 

17

 

 

On September 1, 2022, the Company filed an amended answer with counterclaims against the Golock Plaintiffs and their control persons asserting claims under the Racketeer Influenced and Corrupt Organizations Act (“RICO”) and the Act. On September 23, the Golock Plaintiffs filed a motion to dismiss the counterclaims.

 

On February 14, 2023, the Court granted the motion to dismiss and also dismissed all claims against the Golock Plaintiff’s control persons. The Company remains committed to actively litigating its affirmative defenses under the Act of and RICO.

 

DBW Investments, LLC et al – Trial Court

 

As disclosed in greater detail in the Company’s Form 10-Q, filed May 19, 2023, the Company remains in active litigation with DBW Investments, LLC (“DBW”) and Golock Capital, LLC (“Golock”).

 

On May 22, 2023, a bench trial was held in this dispute. On June 1, 2023, the Court published its opinion and order, wherein the Court found the Company did not successfully establish its criminal usury defense and, thus, ruled in DBW and Golock’s favor on their breach of contract claims.

 

On June 16, 2023, the Court entered an order awarding (a) $1,218,897.62 in favor of Golock, and (b) $268,211.18 in favor of DBW. On July 5, 2023, the Court entered an order awarding Golock and DBW $223,328.20 in attorney’s fees and costs.

 

DBW Investments, LLC et al – Circuit Court

 

On June 2, 2023, the Company appealed the trial court’s decision in favor of DBW Investments, LLC (“DBW”) and Golock Capital, LLC (“Golock”) to the United States Court of Appeals for the Second Circuit, and moved the Second Circuit for a stay of the trial court’s order pending the appeal.

 

On July 27, 2023, the Second Circuit entered an administrative stay of the trial court’s order pending further review by the Second Circuit.

 

The Company’s opening memoranda in support of the appeal is currently due September 13, 2023. The Company remains committed to vigorously defending itself against DBW and Golock. The Company believes its appeal will be successful and has not recorded any liability related to this matter in its condensed financial statements.

 

NOTE 14 – SUBSEQUENT EVENTS

 

Subsequent to September 30, 2023, the Company sold 47,232,113 common shares pursuant to its equity line of credit with GHS and raised approximately $34,000 in gross proceeds. Additionally, the Company issued 80,000,000 shares to one director of the Company as well as 140,078,571 shares to another director of the Company. Also, the company issued a total of 205,000,000 shares to two consultants for services.

 

 

ITEM 2. MANAGEMENT’S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS

 

Forward-Looking Statements

 

The statements in this quarterly report that are not reported financial results or other historical information are “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995, as amended. These statements appear in a number of different places in this report and can be identified by words such as “estimates”, “projects”, “expects”, “intends”, “believes”, “plans”, or their negatives or other comparable words. Also, look for discussions of strategy that involve risks and uncertainties. Forward-looking statements include, among others, statements regarding our business plans and availability of financing for our business. Some forward-looking statements that we may use include, without limitation, those statements that relate to:

 

	●	Competition and market acceptance of our product,
	●	Other risks and uncertainties related to the music industry and our business strategy and the impact of the Covid-19 pandemic on our operations,
	●	Our ability to penetrate the market and continually innovate useful technologies,
	●	Our ability to negotiate and enter into license agreements,
	●	Our ability to raise capital, and
	●	Our ability to protect our intellectual property rights.

 

You are cautioned that any such forward-looking statements are not guarantees and may involve risks and uncertainties. Our actual results may differ materially from those in the forward-looking statements due to risks facing us or due to facts differing from the assumptions underlying our estimates. Some of these risks and assumptions include those set forth in reports and other documents we have filed with or furnished to the United States Securities and Exchange Commission (“SEC”). We advise you that these cautionary remarks expressly qualify in their entirety all forward-looking statements attributable to us or persons acting on our behalf. Unless required by law, we do not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations. However, you should carefully review the reports and other documents we file from time to time with the SEC.

 

Presentation of Information

 

As used in this quarterly report, the terms “we”, “us”, “our” and the “Company” mean VNUE, Inc. and its subsidiaries unless the context requires otherwise.

 

All dollar amounts in this annual report refer to US dollars unless otherwise indicated.

 

Overview

 

We were incorporated as a Nevada corporation on April 4, 2006.

 

Impact of Current Coronavirus (COVID-19) Pandemic on the Company

 

Covid-19 has had a material adverse effect on our live recording business and the music industry in general. Substantially all of our future set.fm and DiscLive business is dependent on the success of public events and gatherings. We believe that the vaccination efforts throughout the world are having a positive impact on the population that may enable more live music events to be held in the future, which would be beneficial to our business; however, there can be no assurances on the timing of when this may occur or whether it will occur at all.

 

 

Overview

 

Our Business

 

We are a music technology company that utilizes our platforms to record live concerts and then sell the content to consumers. We make the content we record available to the set.fm platform, as well as our website, immediately after the show is finished. Our technology helps artists and record labels generate alternative income from the recorded content. We also offer high-end collectible products such as CDs, USB drives and laminates, which feature our fully mixed and mastered live concert content.

 

Until the acquisition of Stage It, described below, we had two products:

 

●

Set.fm™ / DiscLive Network™ - Our consumer app platform allows customers to download and purchase, via their individual mobile device, the concert they just attended. There are also physical collectible products that are recorded and sold at shows as well as online through the Company’s exclusive partner DiscLive Network™. The app itself is free to download and allows for in-app purchases regarding the content. (Currently, this is the only platform that generates any revenue for the Company.)

 

●

Soundstr™ - a comprehensive music identification and rights management Cloud platform that we are developing, when fully deployed, can accurately track and audit public performances of music, creating a more transparent ecosystem for general music licensing and associated royalty payments, which will help ensure the correct stakeholders are compensated through the use of our “big data” collection.

 

While Set.fm™ and Soundstr™ are proprietary marks of the Company, DiscLive, and its related marks and names are not owned by the Company and are owned and utilized by RockHouse Live Media Productions, Inc. The Company has not filed any formal trademark applications relating to Set.fm™ with the United States US Patent and Trademark Office but has been using these marks openly since 2017 and claims common law rights to them.

 

The Company currently only generates revenue from Set.fm and from DiscLive by (a) recording the audio of live concerts and then selling the content “instantly” through its set.fm website, as well as the IOS Set.fm mobile application, and (b) selling content on physical products such as CDs, which are burned on-site where customers can purchase them. Our customers are fans of live music and the bands which we record.

 

Customers want to “take home” their experience of the concerts they attend. Our Company enters into agreements with certain bands and artists and record labels if a particular artist is under contract with the label. Our teams then follow that artist or band while they are on tour and record every show on that tour. Our Company uses its own recording and sound equipment while recording concerts.

 

As we partner with both artists and labels, we market our services on their websites, social media platforms, and mailing lists, as well as our own websites and social networks. Furthermore, partnerships with companies similar to Ticketmaster allow us to market to customers when they buy tickets to see certain artists in concert.

 

On February 13, 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company agreed to acquire Stage It for $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly owned subsidiary of the Company (the “Merger”).

 

 

Pursuant to the Merger Agreement, each of Stage It’s outstanding shares (including common and preferred shares) will be converted into the right to receive the applicable portion of the Merger Consideration. A portion of the Merger Consideration will be paid in cash and take the form of satisfying certain outstanding debt obligations of Stage It, as outlined in a Closing Payment Certificate to the Merger Agreement, and the other portion will be paid in shares of the Company’s common stock or preferred stock, with the actual number of such shares to be issued reduced by the cash component outlaid in the transaction. A portion of the Merger Consideration, $1 million, will be held back for the purposes of satisfying certain contingent obligations of Stage It. Though the period ended September 30, 2023, the Company has paid approximately $1,568,000 in purchase consideration and expenses related to the acquisition.

 

The Merger Agreement also allows for the issuance of earn out shares, not to exceed the overall Merger Consideration, provided that certain EBIDTA requirements are met over the course of 18 months.

 

On February 14, 2022, the Company completed the acquisition of Stage It. As a result of the Closing, Stage It became a wholly-owned subsidiary of the Company. For the acquisition, the Company will issue the initial 135,000,000 shares and pay certain amounts as detailed under Merger Consideration in the Merger Agreement. The price to be paid in cash and stock for the Earnout Shares and Holdback Shares are set forth in the Merger Agreement.

 

With the addition of Stage It (Stage It.com), VNUE will have the ability to livestream concerts and other events, adding to the pool of other live music-focused technology services. Stage It is an established platform where concerts or other live events may be ticketed (just like an in-person event), and fans who pay for tickets may enjoy a performance or other engagement by watching digital video as it occurs on their web browser. For example, an artist can create an event through the platform, then, in advance, let their fans know they can purchase the ability to view the concerts on the Stage It platform. Fans then buy the ability to access these concerts, and at the designated time, the fan may then observe the live performance on Stage It.com.

 

Recent Developments

 

In late July, we announced that the Company is launching an aggressive campaign to deploy its Soundstr Music Recognition Technology in every bar, restaurant and hotel in Key West, FL, and has brought on local resources to have “boots on the ground” for the rollout.

 

Key West is one of the most sought-after vacation spots in the world, attracting around five million tourists per year by planes, boats (including cruise ships), and automobiles. It also boasts a large number of businesses that utilize music. In fact, the famed Duval Street is lined with no less than 143 bars – in less than two miles.

 

Interested businesses may receive the Soundstr Pulse devices for no cost whatsoever. Additionally, in the next several months, VNUE will be offering both playlist functionality – meaning clients will be able to play fully-licensed music directly from Soundstr – as well as the ability to opt-in for advertising, which will help to offset licensing costs that businesses pay. One of the strongest points about Soundstr Pulse is that it does have high-quality audio output capabilities (for use with advertising and for playlists), as well as Bluetooth beacon technology that will be leveraged for non-invasive advertising.

 

Also, in late July, we announced the Company is partnering with Key West’s Barefoot Radio 104.9 and RockHouse Live Key West in collaboration on a new music show centered around local artists and those artists who pass through the exotic and beautiful island on tour.

 

Live and Local at RockHouse Live Key West™ will air every Thursday night, starting September 1, 2022, from 8 PM to 10 PM, 100% live from RockHouse Live Key West’s exclusive Rock Room.

 

In addition to being carried on terrestrial radio by Barefoot 104.9, the show will also air on VNUE’s online and app-based radio station, VNUE Radio, and it will be professionally livestreamed on VNUE’s StageIt.com platform, both of which reach a global audience, and the latter with over a million subscribers. And it will also air on select screens at each of the other RockHouse Live locations in Clearwater Beach, Oxford, MS, and Memphis, TN.

 

 

Two musical artists, which will range from solo artists to full bands, will be featured every week, and will each be interviewed on-site in the RockHouse Live Rock Room, in front of a live audience. Each artist will also take the stage, and during their performance, the radio station will play recordings by each of the featured artists, as well as other local artists who have submitted material for consideration.

 

The Company has been working with Matchbox Twenty, a tour that was to commence in 2020 but has been subsequently delayed until this year due to COVID. The tour commenced in May 2023. As of June 30th, the Company had recorded approximately 29 shows (roughly half of the tour) and has been selling limited edition live CD sets. Together with presales enabled with our “upsell” agreement with Ticketmaster, our sales have been along the lines of our expectations, in the area of 200-300 units per show being sold, sometimes more, not including digital formats which will be introduced for sale upon the completion of the actual tour, and “box sets” which will be offered. Over the course of the tour dates, our crew only encountered a few issues where our services could not be performed, such as weather, or inappropriately excessive fees being imposted by the stagehand union. Overall the tour has been successful.

 

In Q3 we will be putting digital formats and box sets online for sale from the tour and expect a robust interest in these formats.

 

Results of Operations for the nine months ended September 30, 2023, and 2022

 

The following discussion and analysis of our results of operations and financial condition for the three months ended September 30, 2023, and 2022, should be read in conjunction with our condensed consolidated financial statements and related notes included in this report.

 

Revenues

 

The following discussion and analysis of our results of operations and financial condition for the nine months ended September 30, 2023, and 2022, should be read in conjunction with our condensed consolidated financial statements and related notes included in this Report.

 

Revenues

 

For the nine months ended September 30, 2023, we had revenue of $428,552 compared to $233,871 in revenue for the same period ended September 30, 2022, an increase of $194,681. The increase in revenue for the period is primarily attributable to a material increase in revenues at VNUE due to the Rob Thomas tour. We expect that our revenues will increase in future quarters as a result of the decreased impact of Covid-19 and the accompanying lockdowns on businesses, which has been an obstacle for live performances; however, there can be no assurances.

 

Direct Costs of Revenues

 

For the nine months ended September 30, 2023, we had direct costs of revenue of $292,859 compared to $224,786 for the same period ended September 30, 2022.

 

Operating Expenses

 

We incurred operating expenses of $1,060,774 for the nine months ended September 30, 2023, as compared with $17,014,634 for the same period ended September 30, 2022, a decrease of $15,953,860. The operating expense in 2022 include two non- recurring items, $15,300,000 in stock based compensation related to the issuance of Series C voting stock, and $541,667 in amortization of intangible assets. Excluding these two items, the operating expenses in 2022 would have been $1,172,967. The decrease in operating expenses the 2023 period compared to 2022 excluding these two items amounts to $112,193. The decrease in the 2023 period is attributable to decreases in professional fees and payroll expenses, offset by an increase in general and administrative expense.

 

We expect our general and administrative expenses to increase in future quarters with our reporting obligations and the increased expenses associated with increased activity with Stage It operations.

 

 

Other Income / Expenses, Net

 

We recorded other expenses of $198,948 for the nine months ended September 30, 2023, compared to other expense of $931,499 for the same period ended September 30, 2022, a decrease of $732,551. The material decrease in other expense in the 2023 period compared to 2022 were mainly attributable to a reduction in financing cost of $578,351 in 2023 due to equity based financing in the 2023 period compared to high levels of debt based financing in the 2022 period. Additionally, we incurred a loss of $154,200 from the extinguishment of debt in 2022 compared to zero in 2023 period.

 

Net Income (Loss)

 

As a result of the foregoing, we recorded a net loss available to common shareholders of $1,342,687 for the nine months ended September 30, 2023, compared with a net loss available to common shareholders of $18,082,150 for the same period ended September 30, 2022.

 

Liquidity and Capital Resources

 

Since our inception, we have funded our operations primarily through private offerings of our equity securities and loans.

 

The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying condensed consolidated financial statements, during the nine months ended September 30, 2023, the Company used cash in operations of $941,419 and, as of September 30, 2023, had a stockholders’ deficit of $38,151,090_ and negative working capital of $6,929,188. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date of the condensed consolidated financial statements being issued. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern.

 

On September 30, 2023, the Company had cash on hand of $28,433 as compared with cash on hand of $82,807 as of December 31, 2022.

 

The continuation of the Company as a going concern is dependent upon its ability to obtain necessary debt or equity financing to continue operations until it begins generating positive cash flow. Historically, the Company has been able to fund its operations from the proceeds of notes payable and convertible notes.

 

More recently, the Company has been relying on issuances of its preferred stock and its equity line of credit with GHS Investments, LLC (“GHS”), described below, to fund its operations. All other financial commitments have been terminated, and we are looking for new opportunities to fund the Company to supplement our preferred stock and credit line funding. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company can obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in the case of equity financing.

 

During the nine months ended September 30, 2023, the Company utilized its equity line of credit and received $647,645 in gross proceeds from the issuance of 343,790,112 shares of common stock. The Company intends to continue to use its credit line to fund its operations, although there can be no assurance that there will be sufficient availability under the terms of the Equity Financing Agreement.

 

Additionally, the Company issued 199 shares of Preferred B stock to GHS and received $164,000 in gross proceeds.

 

The Company is currently looking for other opportunities to fund the Company to supplement its credit line. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company can obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in the case of equity financing.

 

 

Critical Accounting Policies and Estimates

 

Our management’s discussion and analysis of our financial condition and results of operations is based on our condensed consolidated financial statements, which were prepared in accordance with U.S. generally accepted accounting principles. The preparation of these condensed consolidated financial statements requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the condensed consolidated financial statements, as well as the reported expenses during the reporting periods. Actual results may differ from these estimates under different assumptions or conditions.

 

While our significant accounting policies are more fully described in the notes to our condensed consolidated financial statements appearing elsewhere in this prospectus, we believe that the accounting policies discussed below are critical to our financial results and to the understanding of our past and future performance, as these policies relate to the more significant areas involving management’s estimates and assumptions. We consider an accounting estimate to be critical if: (1) it requires us to make assumptions because the information was not available at the time or it included matters that were highly uncertain at the time we were making our estimate; and (2) changes in the estimate could have a material impact on our financial condition or results of operations. (See Note 1 - Significant and Critical Accounting Policies and Practices in the Company’s Form 10-K for the period ended December 31, 2022, filed with the SEC on April 17, 2023.)

 

Use of Estimates and Assumptions and Critical Accounting Estimates and Assumptions

 

The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Critical accounting estimates are estimates for which (a) the nature of the estimate is material due to the levels of subjectivity and judgment necessary to account for highly uncertain matters or the susceptibility of such matters to change and (b) the impact of the estimate on financial condition or operating performance is material. Management bases its estimates on historical experience and on various assumptions that are believed to be reasonable in relation to the financial statements taken as a whole under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Management regularly evaluates the key factors and assumptions used to develop the estimates utilizing currently available information, changes in facts and circumstances, historical experience, and reasonable assumptions. After such evaluations, if deemed appropriate, those estimates are adjusted accordingly. Actual results could differ from those estimates. Significant estimates include the assumptions used to determine the value of the derivative liabilities, the valuation allowance for the deferred tax asset, and the accruals for potential liabilities.

 

Derivative Financial Instruments

 

The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the condensed consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within 12 months of the balance sheet date.

 

 

Stock-Based Compensation

 

The Company periodically issues stock options and warrants to employees and non-employees in non-capital raising transactions for services and financing costs. The Company accounts for stock option and warrant grants issued and vesting to employees based on the authoritative guidance provided by FASB, where the value of the award is measured on the date of grant and recognized as compensation expense on a straight-line basis over the vesting period. The Company accounts for stock option and warrant grants issued and vesting to non-employees in accordance with the authoritative guidance of the FASB, where the value of the stock compensation is based upon the measurement date as determined at either a) the date at which a performance commitment is reached, or b) at the date at which the necessary performance to earn the equity instruments is complete. Options granted to non-employees are revalued each reporting period to determine the amount to be recorded as an expense in the respective period. As the options vest, they are valued on each vesting date and an adjustment is recorded for the difference between the value already recorded and the then-current value on the date of vesting. In certain circumstances where there are no future performance requirements by the non-employee, option grants are immediately vested and the total stock-based compensation charge is recorded in the period of the measurement date.

 

The fair value of the Company’s stock option and warrant grants are estimated using the Black-Scholes-Merton Option Pricing model, which uses certain assumptions related to risk-free interest rates, expected volatility, expected life of the stock options or warrants, and future dividends. Compensation expense is recorded based upon the value derived from the Black-Scholes-Merton Option Pricing model, and based on actual experience. The assumptions used in the Black-Scholes-Merton Option Pricing model could materially affect compensation expense recorded in future periods.

 

Recent Accounting Pronouncements

 

See Note 2 of the Condensed Consolidated Financial Statement herein for management’s discussion of recent accounting pronouncements.

 

Selected Financial Data

 

Not applicable.

 

Off-Balance Sheet Arrangements

 

We have no significant off-balance sheet arrangements that have or are reasonably likely to have a current or future effect on our financial condition, revenues or expenses, results of operations, liquidity, capital expenditures or capital resources that are material to stockholders.

 

Item 3. Quantitative and Qualitative Disclosures of Market Risk

 

Not applicable.

 

Item 4. Controls and Procedures

 

a) Evaluation of Disclosure Controls and Procedures

 

In connection with the preparation of this quarterly report, an evaluation was carried out by our management, with the participation of our principal executive officer and principal accounting officer, of the effectiveness of our disclosure controls and procedures (as defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934 (the “Exchange Act”)) as of September 30, 2022. Disclosure controls and procedures are designed to ensure that information required to be disclosed in reports filed or submitted under the Exchange Act is recorded, processed, summarized, and reported within the periods specified in the SEC’s rules and forms and that such information is accumulated and communicated to management to allow timely decisions regarding required disclosures.

 

 

Based on that evaluation, and the material weaknesses outlined below under Internal Control Over Financial Reporting, our principal executive officer and principal accounting officer concluded, as of the end of the period covered by this annual report, that, due to weaknesses in our internal controls described below, our disclosure controls and procedures were not effective in recording, processing, summarizing and reporting information required to be disclosed, within the periods specified in the SEC’s rules and forms, and that such information may not be accumulated and communicated to our principal executive officer and principal accounting officer to allow timely decisions regarding required disclosures.

 

b) Internal Control over Financial Reporting

 

A material weakness is a deficiency, or combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the Company’s annual or interim condensed consolidated financial statements will not be prevented or detected on a timely basis. In its assessment of the effectiveness of internal control over financial reporting as of September 30, 2022, the Company determined that there were deficiencies that constituted material weaknesses, as described below.

 

1.	Lack of proper segregation of duties due to limited personnel.
2.	Lack of a formal review process that includes multiple levels of review.

 

3.	Lack of adequate policies and procedures for accounting for financial transactions.
4.	Lack of independent board member(s)
5.	Lack of independent audit committee

 

Management is currently evaluating remediation plans for the above control deficiencies.

 

Changes in Internal Controls over Financial Reporting

 

During the fiscal quarter ended September 30, 2023, there were no changes in our internal control over financial reporting that materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.

 

Limitations on the Effectiveness of Controls

 

Our management, including our Chief Executive Officer and Chief Financial Officer, does not expect that our disclosure controls and procedures or our internal controls will prevent all error and all fraud. A control system, no matter how well conceived and operated, can provide only reasonable, not absolute, assurance that the objectives of the control system are met. Further, the design of a control system must reflect the fact that there are resource constraints and the benefits of controls must be considered relative to their costs. Due to the inherent limitations in all control systems, no evaluation of controls can provide absolute assurance that all control issues and instances of fraud, if any, within our company have been detected.

 

 

PART II - OTHER INFORMATION

 

ITEM 1. LEGAL PROCEEDINGS

 

From time to time, we may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have a material adverse effect on our business, financial condition, or operating results.

 

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS

 

Please see section titled “Liquidity and Capital Resources” above for unregistered sales of equity issuances.

 

During the nine months ended September 30, 2023, the Company issued 343,790,112 shares of common stock and 199 shares of Series B Preferred to GHS Investments, LLC under its equity line.

 

These securities were issued pursuant to Section 4(2) of the Securities Act and/or Rule 506 promulgated thereunder. The holders represented their intention to acquire the securities for investment only and not with a view towards distribution. The investors were given adequate information about us to make an informed investment decision. We did not engage in any general solicitation or advertising. We directed our transfer agent to issue the stock certificates with the appropriate restrictive legend affixed to the restricted stock.

 

ITEM 3. DEFAULTS UPON SENIOR SECURITIES

 

There were no defaults upon senior securities during the period ended September 30, 2023.

 

ITEM 4. MINE SAFETY DISCLOSURES

 

Not applicable

 

ITEM 5. OTHER INFORMATION

 

There is no other information required to be disclosed under this item that was not previously disclosed.

 

 

ITEM 6. Exhibits

 

Exhibits

 

Exhibit Number		Description of Document
31.1*		Certification of the Chief Executive Officer and Principal Accounting Officer Pursuant to Section 302 of the Sarbanes-Oxley Act
32.1*		Certification of the Chief Executive Officer and Principal Accounting Officer Pursuant to Section 906 of the Sarbanes-Oxley Act

 

*

Filed herein

 

 

SIGNATURES

 

Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Registrant: VNUE, INC

 

Date: November 20, 2023

 

By:	/s/ Zach Bair
	Zach Bair
	Chief Executive Officer and Principal Accounting Officer

 

 

Exhibit 31.1

 

CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL ACCOUNTING OFFICER PURSUANT TO 18

U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 AND

PURSUANT TO RULE 13A-14(A) AND RULE 15D-14 UNDER THE SECURITIES ACT OF 1934

 

I, Zach Bair, certify that:

 

1.	I have reviewed this Quarterly Report on Form 10-Q of VNUE, Inc.;

 

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

 

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

 

4.

The registrant’s other certifying officer(s) and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have:

 

a.

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

 

b.

Designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles;

 

c.

Evaluated the effectiveness of the registrant’s disclosure and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluations: and

 

d.

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

 

5.	The registrant’s other certifying officer(s) and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

 

a.

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

 

b.

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting.

 

Registrant	VNUE, Inc.
Date: November 20, 2023	By:	/s/ Zach Bair
		Zach Bair
		Principal Executive Officer and Principal Accounting Officer

 

 

Exhibit 32.1

 

CERTIFICATIONS OF PRINCIPAL EXECUTIVE OFFICER AND PRINCIPAL ACCOUNTING OFFICER PURSUANT

TO SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

(18 U.S.C. SECTION 1350)

 

In connection with the Quarterly Report of VNUE, Inc. (the “Company”) on Form 10-Q for the period ending September 30, 2023, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Zach Bair, Chief Executive Officer and Principal Accounting Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

 

	(1)	The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934, as amended; and
	(2)	The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.

 

Registrant	VNUE, Inc.
Date: November 20, 2023	By:	/s/ Zach Bair
		Zach Bair
		Principal Executive Officer and Principal Accounting Officer

 

v3.23.3

Cover - shares	9 Months Ended
	Sep. 30, 2023	Nov. 20, 2023
Cover [Abstract]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Period End Date	Sep. 30, 2023
Document Fiscal Period Focus	Q3
Document Fiscal Year Focus	2023
Current Fiscal Year End Date	--12-31
Entity File Number	000-53462
Entity Registrant Name	VNUE, INC
Entity Central Index Key	0001376804
Entity Tax Identification Number	98-0543851
Entity Incorporation, State or Country Code	NV
Entity Address, Address Line One	104 West 29th Street
Entity Address, Address Line Two	11th Floor
Entity Address, City or Town	New York
Entity Address, State or Province	NY
Entity Address, Postal Zip Code	10001
City Area Code	833
Local Phone Number	937.5493
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		2,569,524,695

v3.23.3

CONSOLIDATED BALANCE SHEETS (Unaudited) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Current assets:
Cash	$ 28,433	$ 82,807
Prepaid expenses	(0)	130,000
Total current assets	28,433	212,807
Fixed assets, net		9,134
Total assets	28,433	221,941
Current liabilities:
Accounts payable and accrued expenses	2,826,672	2,817,102
Shares to be issued	975,174	975,174
Accrued payroll-officers	211,438	212,250
Dividends payable	429,145	210,486
Notes payable	1,329,865	1,134,262
Deferred revenue	714,613	862,597
Convertible notes payable, net	470,714	470,714
Total current liabilities	6,957,621	6,682,586
Total liabilities	6,957,621	6,682,586
Stockholders’ Deficit
Common stock, par value $0.0001, 4,000,000,000 shares authorized; 2,077,292,582 and 1,676,014,753 shares issued and outstanding, as of September 30, 2023, and December 31, 2022, respectively	207,730	167,601
Additional paid-in capital	31,013,852	30,179,731
Accumulated deficit	(38,151,090)	(36,808,403)
Total stockholders’ deficit	(6,929,188)	(6,460,646)
Total Liabilities and Stockholders’ Deficit	28,433	221,941
Series A Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock, value	320	425
Series B Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock, value
Series C Preferred Stock [Member]
Stockholders’ Deficit
Preferred stock, value

v3.23.3

CONSOLIDATED BALANCE SHEETS (Unaudited) (Parenthetical) - $ / shares	Sep. 30, 2023	Dec. 31, 2022
Common stock, shares par value	$ 0.0001	$ 0.0001
Common stock, shares authorized	4,000,000,000	4,000,000,000
Common stock, shares issued	2,077,292,582	1,676,014,753
Common stock, shares outstanding	2,077,292,582	1,676,014,753
Series A Preferred Stock [Member]
Preferred stock, shares par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	20,000,000	20,000,000
Preferred stock, shares issued	3,200,579	4,250,579
Preferred stock, shares outstanding	3,200,579	4,250,579
Series B Preferred Stock [Member]
Preferred stock, shares par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	2,500	2,500
Preferred stock, shares issued	2,504	2,305
Preferred stock, shares outstanding	2,504	2,305
Series C Preferred Stock [Member]
Preferred stock, shares par value	$ 0.0001	$ 0.0001
Preferred stock, shares authorized	10,000	10,000
Preferred stock, shares issued	3,000	0
Preferred stock, shares outstanding	3,000	0

v3.23.3

CONSOLIDATED STATEMENTS OF OPERATIONS (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
Income Statement [Abstract]
Revenues - related party	$ 53,470	$ 3,090	$ 182,773	$ 9,579
Revenue, net	143,052	96,090	245,779	224,292
Total revenue	196,522	99,180	428,552	233,871
Direct costs of revenue	143,580	72,059	292,859	224,786
Gross profit (loss)	52,942	27,121	135,693	9,085
Operating expenses:
Stock-based compensation				15,300,000
General and administrative expense	59,638	51,586	278,057	171,896
Payroll expenses	105,008	172,374	321,796	419,204
Professional fees	135,486	99,989	460,921	581,867
Amortization of intangible assets		216,667		541,667
Total operating expenses	300,132	540,616	1,060,774	17,014,634
Operating loss	(247,190)	(513,495)	(925,081)	(17,005,549)
Other income
Loss on the extinguishment of debt				(154,200)
Financing costs	(58,335)	(98,394)	(198,948)	(777,299)
Other income (expense), net	(58,335)	(98,394)	(198,948)	(931,499)
Net (loss)	(305,525)	(611,889)	(1,124,029)	(17,937,048)
Preferred B Stock dividends	(69,955)	(62,119)	(218,658)	(145,103)
Net (loss) available to common shareholders	$ (375,480)	$ (674,008)	$ (1,342,687)	$ (18,082,150)
Net loss per common share - basic	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.01)
Net loss per common share - diluted	$ (0.00)	$ (0.00)	$ (0.00)	$ (0.01)
Weighted average common shares outstanding:
Weighted average common shares outstanding basic	1,991,529,123	1,491,415,223	1,853,245,752	1,459,409,678
Weighted average common shares outstanding diluted	1,991,529,123	1,491,415,223	1,853,245,752	1,459,409,678

v3.23.3

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' DEFICIT (Unaudited) - USD ($)	Preferred A Shares [Member]	Preferred B Shares [Member]	Preferred C Shares [Member]	Common Stock [Member]	Additional Paid-in Capital [Member]	Retained Earnings [Member]	Total
Beginning balance, value at Dec. 31, 2021	$ 425			$ 141,177	$ 10,900,652	$ (13,835,294)	$ (2,793,040)
Beginning balance, shares at Dec. 31, 2021	4,250,579			1,411,799,497
Issuance of Preferred B Shares for cash					1,500,000		1,500,000
Issuance of Preferred B Shares for cash, shares		1,500
Financing fee paid in Preferred B shares					42,000		42,000
Financing fee paid in Preferred B shares, shares		35
Beneficial conversion feature of Pref B shares convertible notes					300,000		300,000
Common stock issued for services				$ 600	56,200		56,800
Shares issued for services, shares				6,000,000
Shares issued upon conversion of convertible notes payable				$ 4,148	414,770		418,918
Shares issued upon conversion of convertible notes payable, shares				41,476,963
Net loss						(1,193,106)	(1,193,106)
Balance. September 30, 2023 at Mar. 31, 2022	$ 425			$ 145,925	13,213,622	(15,028,400)	(1,668,428)
Ending balance, shares at Mar. 31, 2022	4,250,579	1,535		1,459,276,460
Issuance of Preferred B Shares for cash					280,000		280,000
Issuance of Preferred B Shares for cash, shares		280
Financing fee paid in Preferred B shares					12,000		12,000
Financing fee paid in Preferred B shares, shares		10
Series B Dividends						(51,915)	(51,915)
Beneficial conversion feature of Preferred B shares					87,000		87,000
Conversion of debt to Preferred B shares					319,200		319,200
Conversion of debt to Preferred B shares, shares		266
Issuance of Preferred C shares to related parties					15,300,000		15,300,000
Issuance of Preferred C shares to related parties, shares		3,000
Acquisition shares issued for Stage It purchase				$ 1,523	152,297		153,820
Acquisition shares issued for Stage It purchase, shares				15,229,726
Net loss						(16,163,122)	(16,163,122)
Balance. September 30, 2023 at Jun. 30, 2022	$ 425			$ 147,448	29,364,119	(31,243,437)	(1,731,445)
Ending balance, shares at Jun. 30, 2022	4,250,579	2,091	3,000	1,474,506,186
Issuance of Preferred B Shares for cash					151,600		151,600
Issuance of Preferred B Shares for cash, shares		164
Financing fee paid in Preferred B shares					14,400		14,400
Financing fee paid in Preferred B shares, shares		12
Shares issued pursuant to the Company’s equity line of credit				$ 4,945	119,314		124,259
Shares issued pursuant to the Company's equity line of credit, shares			49,451,287
Series B Dividends						(62,119)	(62,119)
Beneficial conversion feature of Preferred B shares					45,200		45,200
Acquisition shares issued for Stage It purchase				177	17,721		17,898
Acquisition shares issued for Stage It purchase, shares			1,772,076
Net loss						(611,889)	(611,889)
Balance. September 30, 2023 at Sep. 30, 2022	$ 425			$ 152,570	29,712,354	(31,917,445)	(2,052,096)
Ending balance, shares at Sep. 30, 2022	4,250,579	2,267	3,000	1,525,729,549
Beginning balance, value at Dec. 31, 2022	$ 425			$ 167,601	30,179,731	(36,808,403)	(6,460,646)
Beginning balance, shares at Dec. 31, 2022	4,250,579	2,305	3,000	1,676,014,753
Issuance of Preferred B Shares for cash					111,000		111,000
Issuance of Preferred B Shares for cash, shares		111
Financing fee paid in Preferred B shares					6,000		6,000
Financing fee paid in Preferred B shares, shares		6
Series B Dividends						(65,596)	(65,596)
Shares issued from the Company’s equity line for cash				$ 10,749	247,848		258,597
Shares issued from the Company's equity line for cash, shares				107,494,116
Net loss						(373,404)	(373,404)
Balance. September 30, 2023 at Mar. 31, 2023	$ 425			$ 178,350	30,544,579	(37,247,403)	(6,524,049)
Ending balance, shares at Mar. 31, 2023	4,250,579	2,422	3,000	1,783,508,869
Issuance of Preferred B Shares for cash					81,012		81,012
Issuance of Preferred B Shares for cash, shares		73
Financing fee paid in Preferred B shares					9,988		9,988
Financing fee paid in Preferred B shares, shares		9
Series B Dividends						(83,107)	(83,107)
Shares issued from the Company’s equity line for cash				$ 10,697	246,144		256,841
Shares issued from the Company's equity line for cash, shares				106,968,935
Common stock issued for services				$ 500	18,000		18,500
Shares issued for services, shares				5,000
Net loss						(445,100)	(445,100)
Balance. September 30, 2023 at Jun. 30, 2023	$ 425			$ 189,547	30,899,723	(37,775,610)	(6,685,915)
Ending balance, shares at Jun. 30, 2023	4,250,579	2,504	3,000	1,890,477,804
Conversion of Series A Preferred stock to common stock	$ (105)			$ 5,250	(5,145)
Conversion of Series A Preferred stock to common stock, shares	(1,050,000)			52,500,000
Series B Dividends						(69,955)	(69,955)
Shares issued from the Company’s equity line for cash				$ 12,933	119,274		132,207
Shares issued from the Company's equity line for cash, shares				129,327,061
Net loss						(305,525)	(305,525)
Balance. September 30, 2023 at Sep. 30, 2023	$ 320			$ 207,730	$ 31,013,852	$ (38,151,090)	$ (6,929,188)
Ending balance, shares at Sep. 30, 2023	3,200,579	2,504	3,000	2,077,292,582

v3.23.3

CONSOLIDATED STATEMENTS OF CASH FLOWS (Unaudited) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022
Cash Flows From Operating Activities:
Net (loss)	$ (1,124,029)	$ (17,937,048)
Adjustments to reconcile net income to net cash provided by (used for) operating activities
Depreciation	9,134	19,725
Amortization of intangible assets		541,667
Loss on the extinguishment of debt		154,200
Beneficial conversion feature of Preferred B stock	20,000	432,200
Issuance of Preferred C voting stock		15,300,000
Shares issued for financing costs	23,600	68,400
Shares issued for services	18,500	56,800
Changes in operating assets and liabilities
Prepaid expenses	130,000	364,336
Accounts payable and accrued interest	130,172	220,455
Deferred revenue	(147,984)	4,122
Accrued payroll officers	(812)	25,500
Net cash (used in) operating activities	(941,419)	(749,643)
Cash Flows From Investing Activities:
Purchase of fixed assets		(940)
Acquisition of a business net of cash received		(977,761)
Net cash (used in) investing activities		(978,701)
Cash Flows From Financing Activities:
Proceeds from the Company’s equity line from the sale of common stock	647,645
Proceeds from the private placement of common shares		124,259
Payments on promissory notes		(255,280)
Proceeds from the sale of Series B Preferred Stock	164,400	1,931,600
Proceeds from the issuance of promissory notes	75,000	3,000
Net cash provided by investing activities	887,045	1,803,579
Net Increase (Decrease) In Cash	(54,374)	75,235
Cash At The Beginning Of The Period	82,807	36,958
Cash At The End Of The Period	28,433	112,193
Supplemental disclosure of non-cash information:
Common shares issued for the Stage It acquisition		572,738
Issuance of Preferred C voting shares		15,300,000
Preferred B shares issued upon the conversion of debt and accrued interest		$ 176,410

v3.23.3

ORGANIZATION AND BASIS OF PRESENTATION	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
ORGANIZATION AND BASIS OF PRESENTATION	NOTE 1 – ORGANIZATION AND BASIS OF PRESENTATION   History and Organization   VNUE, Inc. (formerly Tierra Grande Resources, Inc.) (“VNUE”, “TGRI”, or the “Company”) was incorporated under the laws of the State of Nevada on April 4, 2006.   On May 29, 2015, VNUE, Inc. entered into a merger agreement with VNUE Washington, Inc. Pursuant to the terms of the Merger Agreement, all of the outstanding shares of any class or series of VNUE Washington were exchanged for an aggregate of 50,762,987 shares of TGRI common stock. As a result of the Merger, VNUE Washington became a wholly-owned subsidiary of the Company, and the transaction was accounted for as a reverse merger with VNUE Washington deemed the acquiring company for accounting purposes, and the Company deemed the legal acquirer.   The Company is developing technology-driven solutions for Artists, Venues, and Festivals to automate the capturing, publishing, and monetization of their content, as well as protection of their rights.   On February 13, 2022, the Company entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company will acquire Stage It for up to $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly-owned subsidiary of the Company (the “Merger”).   On February 13, 2022, we entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company contracted to acquire Stage It for up to $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly-owned subsidiary of the Company (the “Merger”). At the same time, Stage It and several of the shareholders of Stage It entered into a voting agreement concerning the Merger.   Pursuant to the Merger Agreement, at the closing of the Merger (the “Closing”), each of Stage It’s outstanding shares (including common and preferred shares) were converted into the right to receive the applicable portion of the Merger Consideration. $1,085,450 of the Merger Consideration was paid in cash and satisfaction of certain outstanding debt obligations of Stage It, as outlined in a Closing Payment Certificate of the Merger Agreement, and the other portion was paid in shares of the Company’s common stock or preferred stock, with the actual number of such shares to be issued reduced by the cash component outlaid in the transaction. A portion of the Merger Consideration, $1 million, was held back for the purposes of satisfying certain contingent obligations of Stage It.   The Merger Agreement provides for the issuance of earnout shares which the company estimates will not be achieved.   On February 14 2022, the Company completed the acquisition of Stage It. As a result of the Closing, Stage It became a wholly-owned subsidiary of the Company. For the acquisition, the Company issued the initial 135,000,000 shares, paid certain amounts to Stage It vendors and will potentially pay additional amounts as detailed under Merger Consideration in the Merger Agreement.

v3.23.3

GOING CONCERN	9 Months Ended
	Sep. 30, 2023
Organization, Consolidation and Presentation of Financial Statements [Abstract]
GOING CONCERN	NOTE 2 – GOING CONCERN   The accompanying condensed consolidated financial statements have been prepared on a going concern basis, which contemplates the realization of assets and the settlement of liabilities and commitments in the normal course of business. As reflected in the accompanying condensed consolidated financial statements as of September 30, 2023, the Company had $28,433 in cash on hand, had negative working capital of $6,929,188 and had an accumulated deficit of $38,151,090. Additionally, for the nine months ended September 30, 2023, the Company used $941,419 in cash from operating activities. These factors raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date of the condensed consolidated financial statements being issued. The ability of the Company to continue as a going concern is dependent upon the Company’s ability to raise additional funds and implement its business plan. The Company does not have any commitments for additional capital.   The condensed consolidated financial statements do not include any adjustments that might be necessary if the Company is unable to continue as a going concern. In addition, the Company’s independent registered public accounting firm, in its report on the Company’s September 30, 2023, condensed consolidated financial statements, has raised substantial doubt about the Company’s ability to continue as a going concern.   The continuation of the Company as a going concern is dependent upon its ability to obtain necessary debt or equity financing to continue operations until it begins generating positive cash flow. Historically, the Company has been able to fund its operations from the proceeds of notes payable and convertible notes. No assurance can be given that any future financing will be available or, if available, that it will be on terms that are satisfactory to the Company. Even if the Company can obtain additional financing, it may contain undue restrictions on our operations, in the case of debt financing, or cause substantial dilution for our stockholders, in the case of equity financing.

v3.23.3

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES	NOTE 3 – SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES   Basis of Consolidation   The accompanying condensed consolidated financial statements have been prepared in accordance with the Financial Accounting Standards Board (“FASB”) “FASB Accounting Standard Codification™” (the “Codification”), which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of condensed consolidated financial statements in conformity with generally accepted accounting principles (“GAAP”) in the United States.   The Company consolidates its results with its wholly-owned subsidiary, Stage It Corp.   Revenue Recognition   The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.   Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed, the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer; however, there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as an agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production.   The Company also recognizes revenue from the sale of CDs and USB drives that contain the recording of live concerts and are made available to concert attendees immediately after the show and online. Revenue is recognized on the sale of a product when our performance obligation is completed, which is when the risk of loss transfers to our customers and the collection of the receivable is reasonably assured, which generally occurs when the product is purchased.   As of September 30, 2023 deferred revenue amounted to $714,613. As of September 30, 2023, deferred revenue was comprised of unredeemed notes at Stage It that have been purchased by customers but not used toward any events. When these notes are redeemed, on average, the performing artists will receive approximately 80%, and the Company will record 20% of the value of these notes as revenue.   Use of Estimates   The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates.   Stock Purchase Warrants   The Company accounts for warrants issued to purchase shares of its common stock as equity in accordance with FASB ASC 480, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock, Distinguishing Liabilities from Equity.   Fair Value of Financial Instruments   The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value:     ● Level 1 — Quoted prices in active markets for identical assets or liabilities.         ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.         ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.   The carrying amounts of financial instruments, such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.   Derivative Financial Instruments   The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. There were no derivative liabilities outstanding as of September 30, 2023 and December 31, 2022.   Income (Loss) per Common Share   Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that is then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on September 30, 2023, because their impact would have been anti-dilutive.   Property and Equipment   Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The carrying amount and accumulated depreciation of assets sold or retired are removed from the accounts in the year of disposal and any resulting gain or loss is included in the results of operations. The estimated useful lives of property and equipment are as follows:   Schedule of property plant equipment estimated useful lives       Computers, software, and office equipment   3 years   Furniture and fixtures   7 years     As of September 30, 2023, the Company’s property was fully depreciated. Depreciation expense for the nine months ended September 30, 2023, and 2022, amounted to $9,134 and $19,725, respectively.   Goodwill and Intangible Assets   Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. The goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets consist primarily of customer relationships, trademarks, and product formulations. The useful life of these customer relationships is estimated to be three years.   Goodwill is not amortized but is subject to annual impairment testing unless circumstances dictate more frequent assessments. The Company performs an annual impairment assessment for goodwill during the fourth quarter of each year and more frequently whenever events or changes in circumstances indicate that the fair value of the asset may be less than the carrying amount. Goodwill impairment testing compares the fair value of the reporting unit to its carrying amount. The fair value of the reporting unit is determined by considering both the income approach and market approaches. The fair values calculated under the income approach and market approaches are weighted based on circumstances surrounding the reporting unit. Under the income approach, the Company determines fair value based on estimated future cash flows of the reporting unit, which are discounted to the present value using discount factors that consider the timing and risk of cash flows. For the discount rate, the Company relies on the capital asset pricing model approach, which includes an assessment of the risk-free interest rate, the rate of return from publicly traded stocks, the Company’s risk relative to the overall market, the Company’s size and industry and other Company-specific risks. Other significant assumptions used in the income approach include the terminal value, growth rates, future capital expenditures, and changes in future working capital requirements. The market approaches use key multiples from guideline businesses that are comparable and are traded on a public market. If the fair value of the reporting unit is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess. As of December 31, 2022, the Company determined that its goodwill and intangibles were fully impaired, and as a result, recorded an impairment of goodwill and intangible assets amounting to $4,261,683 in its Statements Operations for the year ended December 31, 2022.   Recently Issued Accounting Pronouncements   In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04, and ASU 2019-05 (collectively, “Topic 326”). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. The Company will be required to adopt this ASU for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The adoption of Topic 326 is not expected to have a material effect on the Company’s condensed consolidated financial statements and financial statement disclosures.

v3.23.3

PREPAID EXPENSE	9 Months Ended
	Sep. 30, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
PREPAID EXPENSE	NOTE 4 – PREPAID EXPENSE   As of September 30, 2023 and December 31, 2022, the balances in prepaid expenses was $-0- and $130,000.   Schedule of prepaid expense                     September 30, 2023     December 31, 2022   Matchbox Twenty (“MT”) agreement   $       $ 100,000   Deposit with joint venture partner             30,000   Total prepaid expenses   $       $ 130,000     The MT prepaid expense in both periods relates to a January 9, 2020 agreement entered into by the Company with recording and performance artist, Matchbox Twenty (“MT Agreement”), to record its 2020 tour and sell limited edition double CD sets, download cards, and digital downloads. As part of the deal, the Company agreed to pay an advance of $100,000 against sales to MT and its affiliated companies, which was paid in full in installments, with the last installment of $40,000 paid on March 4, 2020.

v3.23.3

RELATED PARTY TRANSACTIONS	9 Months Ended
	Sep. 30, 2023
Related Party Transactions [Abstract]
RELATED PARTY TRANSACTIONS	NOTE 5 – RELATED PARTY TRANSACTIONS   DiscLive Network   On July 10, 2017, the Company entered into a Licensing Agreement with RockHouse Live Media Productions, Inc., DBA “DiscLive” or “DiscLive Network” (“DiscLive”) to formalize the terms of the Strategic Alliance entered into by the Company with DiscLive on July 21, 2016. VNUE has acquired an exclusive license from DiscLive, for a period of three years unless earlier terminated under the Agreement, for the use of all its assets, including but not limited to the DiscLive brand, website (including eCommerce platform), intellectual property, inventory, equipment, trade secrets and anything related to its business of “instant live” recording. Under the terms of the Agreement, DiscLive granted the Company a worldwide exclusive license.   In exchange for the license, DiscLive will receive a license fee equal to five percent (5%) of any sales derived from the sale and use of the products and services. DiscLive is controlled by our Chief Executive Officer. Revenues of $182,773 and $9,579 for the periods ended September 30, 2023, and 2022, respectively, were recorded using the assets licensed under this agreement. For the periods ended September 30, 2023, and 2022 the fees would have amounted to $9,139 and $479, respectively. The Company’s Chief Executive Officer agreed to temporarily waive the right to receive these license fees for both years and has never taken any fees pursuant to this agreement.   Advances from Officers/Stockholders   From time to time, officers/stockholders of the Company advance funds to the Company for working capital purposes. During the year ended December 31, 2021, the Company’s Chief Executive Officer advanced $10,000 to the Company on an interest-free basis. That amount was repaid in the fourth quarter of 2022.

v3.23.3

BUSINESS ACQUISITION	9 Months Ended
	Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]
BUSINESS ACQUISITION	NOTE 6 – BUSINESS ACQUISITION   On February 13, 2022, VNUE, Inc. (the “Company”) entered into an Agreement and Plan of Merger (the “Merger Agreement”) with VNUE Acquisition Inc., a Delaware corporation and wholly-owned subsidiary of the Company (“MergerCo”), Stage It Corp., a Delaware corporation (“Stage It”), and the stockholders’ representative for Stage It, pursuant to which the Company will acquire Stage It for up to $10 million (the “Merger Consideration”), by merging MergerCo with and into Stage It, with Stage It continuing as the surviving entity and wholly owned subsidiary of the Company (the “Merger”).   Pursuant to the Merger Agreement, and subject to the terms and conditions set forth therein, at the closing of the Merger (the “Closing”), each of Stage It’s outstanding shares (including common and preferred shares) will be converted into the right to receive the applicable portion of the Merger Consideration. A portion of the Merger Consideration will be paid in cash and take the form of satisfying certain outstanding debt obligations of Stage It, as outlined in a Closing Payment Certificate of the Merger Agreement, and the other portion will be paid in shares of the Company’s common stock or preferred stock, with the actual number of such shares to be issued reduced by the cash component outlaid in the transaction. A portion of the Merger Consideration, $1 million, will be held back to satisfy certain contingent obligations of Stage It.   The Merger Agreement also allows for the issuance of earn-out shares, not to exceed the overall Merger Consideration, provided that certain EBIDTA requirements are met over the course of 18 months.   On February 13, 2022, the Company, Stage It and the shareholders of Stage It entered into a voting agreement concerning the Merger.   On February 14, 2022, the Company completed the acquisition of Stage It. As a result of the Closing, Stage It became a wholly-owned subsidiary of the Company. For the acquisition, the Company will issue the initial 135,000,000 shares and pay certain amounts as detailed under Merger Consideration in the Merger Agreement. The price to be paid in cash and stock for the Earnout Shares and Holdback Shares are set forth in the Merger Agreement.   The Merger Agreement has been included to provide investors with information regarding its terms. The representations, warranties, and covenants contained in the Merger Agreement were made only for the purposes of the Merger Agreement, were made as of specific dates, were made solely for the benefit of the parties to the Merger Agreement, and may not have been intended to be statements of fact, but rather as a method of allocating risk and governing the contractual rights and relationships among the parties to the Merger Agreement. In addition, such representations, warranties, and covenants may have been qualified by certain disclosures not reflected in the text of the Merger Agreement and may apply standards of materiality and other qualifications and limitations in a way that is different from what may be viewed as material by the Company’s shareholders. None of the Company’s shareholders or any other third party should rely on the representations, warranties, and covenants, or any descriptions thereof, as characterizations of the actual state of facts or conditions of the Company, the Company, Merger Sub, or any of their respective subsidiaries or affiliates   For the acquisition of Stage It, the following table summarizes the acquisition date fair value of the consideration paid, identifiable assets acquired and liabilities assumed:   Consideration paid   Schedule of fair value of consideration         Common stock issued, 41,476,963 shares of the Company’s restricted common stock valued at $0.0101 per share   $ 418,917   Common stock issuable, 93,523,037 shares of the Company’s restricted common stock valued at $0.0101 per share     944,583   Net liabilities assumed     2,871,066   Cash paid     1,085,450   Fair value of total consideration paid   $ 5,320,016     Net assets acquired and liabilities assumed   Schedule of net asset acquired and liabilities assumed         Cash and cash equivalents   $ 107,689   Computer equipment     36,882   Total assets     144,571             Accounts payable and accrued liabilities     1,711,349   Notes payable     526,385   Deferred revenue     777,903   Total liabilities     3,015,637             Net liabilities assumed   $ 2,871,066     The Company has allocated the fair value of the total consideration paid of $10,400,000 to goodwill and $2,600,000 to intangible assets with a life of three years. The value of goodwill represents Stage It’s ability to generate profitable operations going forward. Management estimated the provisional fair values of the intangible assets and goodwill on March 31, 2022, and did not complete a valuation study with an independent third party. During the year ended December 31, 2022, the Company recorded $758,333 in amortization expense.   On December 31, 2022, the Company, based on its internal analysis, estimated that its Stage It subsidiary would not achieve its Earnout and that all of the goodwill and intangible assets relating to the acquisition of Stage It was fully impaired. As a result, the Company recorded an impairment of goodwill and intangible assets charge net of the earnout reversal of $4,262,683 on its Statements of Operations for the year ended December 31, 2022.   The amount of $4,262,683 was calculated as follows:   Schedule of net impairment         Goodwill impairment   $ 10,400,000   Intangible assets impairment     1,542,847   Reversal of Earnout liability     (7,679,984 ) Net impairment   $ 4,262,863

v3.23.3

DEFERRED REVENUE	9 Months Ended
	Sep. 30, 2023
Revenue Recognition and Deferred Revenue [Abstract]
DEFERRED REVENUE	NOTE 7 – DEFERRED REVENUE   As of September 30, 2023 deferred revenue amount to $714,613 and was comprised of unredeemed notes at Stage It that have been purchased by customers but not used toward any events. When these notes are redeemed, on average, the performing artists will receive 80%, and the Company will record 20% of the value of these notes as revenue.

v3.23.3

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	9 Months Ended
	Sep. 30, 2023
Payables and Accruals [Abstract]
ACCOUNTS PAYABLE AND ACCRUED LIABILITIES	NOTE 8 – ACCOUNTS PAYABLE AND ACCRUED LIABILITIES   Accounts payables are recognized initially at the transaction price and subsequently measured at the undiscounted amount of cash or other consideration expected to be paid. Accrued expenses are recognized based on the expected amount required to settle the obligation or liability.   The following table sets forth the components of the Company’s accrued liabilities on September 30, 2023, and December 31, 2022:   Schedule of accrued liabilities                     September 30, 2023     December 31, 2022   Accounts payable and accrued expenses   $ 2,444,903     $ 2,389,231   Accrued interest     236,510       282,612   Soundstr Obligation     145,259       145,259   Total accounts payable and accrued liabilities   $ 2,826,672     $ 2,817,102

v3.23.3

SHARES TO BE ISSUED	9 Months Ended
	Sep. 30, 2023
Shares To Be Issued
SHARES TO BE ISSUED	NOTE 9 – SHARES TO BE ISSUED   As of September 30, 2023 and December 31, 2022, the balances of shares to be issued were 975,174 and $975,174, respectively. The balance as of September 30, 2023 is comprised of the following:   ● As of December 31, 2022, the Company had not yet issued 5,204,352 shares of common stock with a value of $247,707 for past services provided and for an acquisition in previous years.     ● During the year ended December 31, 2022, pursuant to the acquisition of Stage It described throughout this Report, an additional 72,026,422 shares remain issuable to Stage It shareholders valued at $727,647.

v3.23.3

NOTES PAYABLE	9 Months Ended
	Sep. 30, 2023
Notes Payable
NOTES PAYABLE	NOTE 10 – NOTES PAYABLE   The balance of the Notes Payable outstanding as of September 30, 2023, and December 31, 2022, was $1,329,865 and $1,134,262 respectively. The balances as of September 30, 2023, were comprised of numerous 8% notes for $1,052,761 due to Ylimit, payable on September 30, 2023, and $277,104 in notes due to former Stage It shareholders. During the three months ended September 30, 2023 the company entered into a loan modification agreement with Ylimit. Under the terms of the agreement Ylimit converted $102,603 in accrued interest into loan principal, and extended the maturity date of its outstanding promissory note to September 30, 2024. Also during the three months ended September 30, 2023 Ylimit advanced $50,000 to the company. This amount is included in the outstanding balance of $1,052,761.

v3.23.3

CONVERTIBLE NOTES PAYABLE	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
CONVERTIBLE NOTES PAYABLE	NOTE 11 – CONVERTIBLE NOTES PAYABLE   Convertible notes payable consist of the following:   Schedule of convertible notes payable                     September 30, 2023     December 31, 2022   Various Convertible Notes(a)   $ 131,703     $ 131,703   Golock Capital, LLC Convertible Notes(b)     339,011       339,011   Total Convertible Notes   $ 470,714     $ 470,714       (a) This total is comprised of six convertible notes with five different noteholders. With the exception of one note for $28,500 due to a former related party which is interest free, all of the remaining notes at a 10% interest rate are past due their maturity. The Company has not received any default notices on these notes and continues to accrue interest on these notes. Additionally, $73,204 of these notes due to DBW Investments is in dispute. (b) On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Golock”) in the principal amount of $40,000 with an interest rate of 10% per annum and a maturity date of November 2, 2018. The note included an original issue discount of $5,000. The note is convertible into shares of the Company’s common stock at $0.015 per share. As additional consideration for Golock to enter into this agreement with the Company, the Company issued warrants to Golock to acquire in the aggregate 2,500,000 shares of the Company’s common stock at an exercise price of $0.015 per share that expire three years from the date of grant. The relative fair value of the warrants, the original issue discount, and the beneficial conversion feature totaling $40,000 was recorded as a debt discount and will be amortized to interest expense over the term of the note. On November 5, 2018, the Company amended the notes above by changing the conversion feature for the aggregate notes to be convertible into shares of common stock of the Company at the lower of (i) $0.015 per share or, (ii) 58% of the lowest closing bid price in the 20 trading days prior to the day that Golock requests conversion. This feature gave rise to a derivative liability of $553,000 at the date of issuance, as discussed below. The amendment also increased the principal face amount of notes to include accrued interest, and an additional $43,250 was added to the principal, which was recorded to financing costs. The aggregate balance of the notes outstanding, and the related debt discount was $302,067 and $0, respectively, as of December 31, 2018.   On April 29, 2019, Golock entered into an amendment with the Company to extend the maturity of the Notes until July 31, 2019. In return, Golock received several concessions. They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months, exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that Golock requested conversion. During the year ending December 31, 2019, the Company issued new notes payable of $53,331, and $23,102 of notes and accrued interest were converted into 100,000,000 shares of common stock. The balance of the notes outstanding on December 31, 2019 was $339,010. As of December 31, 2019, $285,679 of these notes were past due. As of September 30, 2023, all of the Golock notes amounting to $339,011 were past due.   As a result, Golock has assessed the Company additional penalties and interest of $1,172,782. The Company disagrees with the accrued interest and penalties due to Golock. Initially, the Company recorded this amount as a liability on its balance during 2021. Subsequently, during the three-month period ended September 30, 2021, the Company obtained a legal opinion supporting its position that these charges were egregious and reversed the liability on its balance sheet. The Company intends to litigate this amount as well as the validity of the principal and interest outstanding if a settlement on a vastly reduced amount cannot be reached.

v3.23.3

STOCKHOLDERS’ DEFICIT	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
STOCKHOLDERS’ DEFICIT	NOTE 12 – STOCKHOLDERS’ DEFICIT   Common stock   The Company has authorized 4,000,000,000 shares of $0.0001 par value common stock. As of September 30, 2023, and December 31, 2022, there were 2,077,292,582 and 1,676,014,753 shares of common stock issued and outstanding, respectively. During the nine months ended September 30, 2023, the Company sold 343,790,112 common shares pursuant to the terms of its equity line and raised $647,645 in gross proceeds.   Preferred Stock Series A   On July 2, 2019, the Company filed a Certificate of Amendment (the “Charter Amendment”) to the Company’s Articles of Incorporation (as amended to date, the “Articles of Incorporation”) with the Secretary of State of the State of Nevada. The Charter Amendment increased the Company’s capitalization to 2,000,000,000 shares of Common Stock and 20,000,000 shares of Preferred Stock, of which 5,000,000 were designated as Series A Convertible Preferred Stock.   On May 22, 2019, the Company authorized and designated a class of Series A Convertible Preferred Stock (“Series A Preferred Stock”), in accordance with a Certificate of Designation filed with the State of Nevada (the “Series A Designation”). It subsequently issued 4,126,776 restricted shares of Series A Preferred Stock to various employees and service providers to compensate and reward them for services and to incentivize them to provide continued service to the Company. The Series A Preferred Stock receives relative rights and preferences under terms and conditions set forth in the Certificate of Designation of the Preferred Stock.   Pursuant to the Series A Designation, each share of Series A Preferred Stock may be converted into 50 shares of common stock of the Company. The Series A Preferred Stockholders shall be entitled to share among dividends with the common stock shareholders of the Company on an as-converted basis. The Series A Preferred Stockholders shall vote with the common stock as a single class, on a 100 to 1 basis, such that for every share of Series A Preferred Stock held, such shares shall entitle the holder to cast 100 votes. The holders of the Series A Preferred Stock have no liquidation or redemption preference rights but get treated as common stockholders on an as converted basis.   The Company believes that the issuance of the Series A Preferred Stock was exempt from the registration requirements under the Securities Act of 1933, as amended pursuant to Section 4(a)(2) of the Act in that said transaction did not involve a public solicitation and said restricted shares were issued to only a small number of employees and consultants with an ongoing relationship with the Company.   As of September 30, 2023 and 2022 the Company had 20,000,000 shares of $0.0001 par value preferred stock authorized and there were 3,200,579 and 4,250,579 shares of Series A Preferred Stock issued and outstanding, respectively. During the three months ended September 30, 2023 a shareholder converted 1,050,000 shares of Series A stock into 52,500,000 common shares.   Preferred Stock Series B (Update)   On January 3, 2022, the Company authorized and designated a class of 2,500 shares, par value $0.0001, of Series B Convertible Preferred Stock (“Series B Preferred Stock”), in accordance with a Certificate of Designation filed with the State of Nevada (the “Series 5 Designation”).   As of September 30, 2023 there were 2,504 shares of Series B Preferred Stock Outstanding.   During the nine months ended September 30, 2023, the Company issued 199 Preferred B shares to GHS and raised $164,000 in gross proceeds.   Warrants   In connection with the issuance of Series B Preferred Stock to the Company described in Note 14, the Company issued _______ warrants, with a five-year life, at an average strike price of $_________.   A summary of warrants is as follows:   Schedule of warrants                     Number of Warrants     Weighted Average Exercise   Balance outstanding, December 31, 2020     23,805,027           Warrants expired or forfeited     (8,004,708 )     -   Balance outstanding and exercisable, December 31, 2021     15,800,319           Warrants exercised or forfeited     (15,800,319 )         Warrants granted during the year ended December 31, 2022     279,655,690           Balance outstanding and exercisable, December 31, 2022     279,655,690           Warrants exercised or forfeited     -           Warrants granted during the nine months ended September 30, 2023     -           Balance outstanding and exercisable, September 30, 2023     335,440,817         (a)      (a) The strike price on these warrants range between $0.01122 and $0.00264 and are subject to adjustment based on the market price of the Company’s stock price.   Information relating to outstanding warrants on September 30, 2023, summarized by exercise price, is as follows:   The weighted-average remaining contractual life of all warrants outstanding and exercisable on September 30, 2023 is approximately 3.75 years. As of September 30, 2023 these warrants has no intrinsic value.   Preferred Stock Series C   On May 25, 2022, the Company authorized and designated a class of 10,000 shares of Series C Preferred Stock, par value $0.0001. The holders of the Series C Preferred Stock shall have the right to cast one million (1,000,000) votes for each share held of record on all matters submitted to a vote of holders of the Company’s common stock. On the same date, the Company issued to each of Zach Bair, Chief Executive Officer & Chairman, Anthony Cardenas, Chief Financial Officer and Director, and Lou Mann, Executive Vice President and Director, 1,000 shares of this newly created Series C Preferred Stock for services rendered. These share which represented 3,000,000,000 (billion) votes, was valued at the trading price of the Company’s securities of $0.0051 on the date of Board of Director approval. As a result, the Company recorded a non-cash charge of $15,300,000 on its Statement of Operation for the three months ended September 30, 2022.   As of September 30, 2023 and December 31, 2022, there were 3,000 shares of Series C Preferred Stock outstanding.

v3.23.3

COMMITMENT AND CONTINGENCIES	9 Months Ended
	Sep. 30, 2023
Commitments and Contingencies Disclosure [Abstract]
COMMITMENT AND CONTINGENCIES	NOTE 13 – COMMITMENT AND CONTINGENCIES   Litigation   Legal Matters   In the matter of VNUE, Inc. v. Power Up Lending Group, Ltd. On October 6, 2021, the Company commenced an action against Power Up Lending Group, Ltd. (“Power Up”) and Curt Kramer (“Kramer”) (Power Up and Kramer together, the “Power Up Parties”) in the United States District Court for the Eastern District of New York. The complaint alleges that: (1) Power Up is an unregistered dealer acting in violation of Section 15(a) of the Securities Exchange Act of 1934 (the “Act”) and, pursuant to Section 29(b) of the Act, the Company is entitled to recessionary relief from certain convertible promissory notes (“Notes”) and securities purchase agreements (“SPAs”) entered into by the Company and Power Up; (2) Kramer is liable to the Company as the control person of Power Up pursuant to Section 20(a) of the Act; and (3) Power Up is liable to the Company for unjust enrichment arising from the Notes and SPAs.   On December 10, 2021, the Power Up Parties filed their pre-motion conference request letter with the Court regarding their forthcoming motion to dismiss the Company’s complaint. On December 17, 2021, the Company filed its opposition thereto. On January 26, 2022, the Company filed its amended complaint, which asserted the same causes of action set forth in the initial complaint, and further alleged that Power Up made material misstatements in connection with the purchase and sale of the Company’s securities in violation of Section 10(b) of the Act and, thus, the Company is entitled to recessionary relief from the Notes and SPAs pursuant to Section 29(b) of the Act.   On February 9, 2022, the Court ordered an initial conference. The initial conference is currently scheduled for May 16, 2022, at 12:00 p.m. (EST). As of the date hereof, the Company intends to litigate its claims for relief against the Power Up Parties.   On June 7, 2022, the Company filed a voluntary dismissal of the action because the parties reached a confidential settlement.   Golock Capital, LLC and DBW Investments, LLC v. VNUE, Inc. On September 29, 2021, Golock Capital, LLC (“Golock”) and DBW Investments, LLC (“DBW”) (Golock and DBW together, the “Golock Plaintiffs”) commenced an action against the Company in the United States District Court for the Southern District of New York. The Golock Plaintiffs’ complaint alleges that the Company is in breach of certain convertible promissory notes and securities purchase agreements separately entered into with Golock and DBW and seeks declaratory judgment, injunctive relief, and specific performance against the Company.   On December 2, 2021, the Golock Plaintiffs filed their amended complaint, which asserted the same causes of action set forth in the initial complaint and an additional cause of action for unjust enrichment. On January 19, 2022, the Company filed its answer with affirmative defenses to the amended complaint. As to its affirmative defenses, the Company asserted that the Golock Plaintiff’s claims are barred because: (1) the Golock Plaintiffs are unregistered dealers acting in violation of Section 15(a) of the Securities Exchange Act of 1934 (the “Act”), and, pursuant to Section 29(b) of the Act, that the Company is entitled to recessionary relief from the certain convertible promissory notes and securities purchase agreements at issue in the amended complaint; and (2) that the convertible promissory notes are, in fact, criminally usurious loans that impose interest onto the Company at a rate that violates New York Penal Law § 190.40 and, therefore, the subject convertible notes are void ab initio pursuant to New York’s usury laws.   On January 20, 2022, the Court ordered that the parties submit a joint letter in lieu of a pretrial conference on or before February 3, 2022. As of the date hereof, the Company intends to vigorously defend itself against the Golock Plaintiff’s claims.   On September 1, 2022, the Company filed an amended answer with counterclaims against the Golock Plaintiffs and their control persons asserting claims under the Racketeer Influenced and Corrupt Organizations Act (“RICO”) and the Act. On September 23, the Golock Plaintiffs filed a motion to dismiss the counterclaims.   On February 14, 2023, the Court granted the motion to dismiss and also dismissed all claims against the Golock Plaintiff’s control persons. The Company remains committed to actively litigating its affirmative defenses under the Act of and RICO.   DBW Investments, LLC et al – Trial Court   As disclosed in greater detail in the Company’s Form 10-Q, filed May 19, 2023, the Company remains in active litigation with DBW Investments, LLC (“DBW”) and Golock Capital, LLC (“Golock”).   On May 22, 2023, a bench trial was held in this dispute. On June 1, 2023, the Court published its opinion and order, wherein the Court found the Company did not successfully establish its criminal usury defense and, thus, ruled in DBW and Golock’s favor on their breach of contract claims.   On June 16, 2023, the Court entered an order awarding (a) $1,218,897.62 in favor of Golock, and (b) $268,211.18 in favor of DBW. On July 5, 2023, the Court entered an order awarding Golock and DBW $223,328.20 in attorney’s fees and costs.   DBW Investments, LLC et al – Circuit Court   On June 2, 2023, the Company appealed the trial court’s decision in favor of DBW Investments, LLC (“DBW”) and Golock Capital, LLC (“Golock”) to the United States Court of Appeals for the Second Circuit, and moved the Second Circuit for a stay of the trial court’s order pending the appeal.   On July 27, 2023, the Second Circuit entered an administrative stay of the trial court’s order pending further review by the Second Circuit.   The Company’s opening memoranda in support of the appeal is currently due September 13, 2023. The Company remains committed to vigorously defending itself against DBW and Golock. The Company believes its appeal will be successful and has not recorded any liability related to this matter in its condensed financial statements.

v3.23.3

SUBSEQUENT EVENTS	9 Months Ended
	Sep. 30, 2023
Subsequent Events [Abstract]
SUBSEQUENT EVENTS	NOTE 14 – SUBSEQUENT EVENTS   Subsequent to September 30, 2023, the Company sold 47,232,113 common shares pursuant to its equity line of credit with GHS and raised approximately $34,000 in gross proceeds. Additionally, the Company issued 80,000,000 shares to one director of the Company as well as 140,078,571 shares to another director of the Company. Also, the company issued a total of 205,000,000 shares to two consultants for services.

v3.23.3

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Policies)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Basis of Consolidation	Basis of Consolidation   The accompanying condensed consolidated financial statements have been prepared in accordance with the Financial Accounting Standards Board (“FASB”) “FASB Accounting Standard Codification™” (the “Codification”), which is the source of authoritative accounting principles recognized by the FASB to be applied by nongovernmental entities in the preparation of condensed consolidated financial statements in conformity with generally accepted accounting principles (“GAAP”) in the United States.   The Company consolidates its results with its wholly-owned subsidiary, Stage It Corp.
Revenue Recognition	Revenue Recognition   The Company recognizes revenue in accordance with Accounting Standards Codification (“ASC”) 606, Revenue from Contracts. ASC 606 creates a five-step model that requires entities to exercise judgment when considering the terms of contracts, which includes (1) identifying the contracts or agreements with a customer, (2) identifying our performance obligations in the contract or agreement, (3) determining the transaction price, (4) allocating the transaction price to the separate performance obligations, and (5) recognizing revenue as each performance obligation is satisfied. The Company only applies the five-step model to contracts when it is probable that the Company will collect the consideration it is entitled to in exchange for the services it transfers to its clients.   Stage It receives revenue through a percentage of ticket sales and tipping. This show-based revenue creates a pool that is shared with the performing artist. Once a show is completed, the revenue that has been created through tickets and tips is allocated. Typically, Stage It retains 20% of the revenue as an agent and the artist receives 80% of the revenue as the performer; however, there are occasions when the profit split has different ratios. Revenue is recognized once a show is complete and the performance obligation to the consumer has been met. Since Stage It acts as an agent, revenue is recorded on a net basis only on the 20% portion, less direct expenses such as broadcast costs, merchant processing fees, bank services charges, license fees and the cost of production.   The Company also recognizes revenue from the sale of CDs and USB drives that contain the recording of live concerts and are made available to concert attendees immediately after the show and online. Revenue is recognized on the sale of a product when our performance obligation is completed, which is when the risk of loss transfers to our customers and the collection of the receivable is reasonably assured, which generally occurs when the product is purchased.   As of September 30, 2023 deferred revenue amounted to $714,613. As of September 30, 2023, deferred revenue was comprised of unredeemed notes at Stage It that have been purchased by customers but not used toward any events. When these notes are redeemed, on average, the performing artists will receive approximately 80%, and the Company will record 20% of the value of these notes as revenue.
Use of Estimates	Use of Estimates   The preparation of the condensed consolidated financial statements in conformity with accounting principles generally accepted in the U.S requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities, disclosure of contingent assets and liabilities at the financial statement date and reported amounts of revenue and expenses during the reporting period. Significant estimates include the valuation allowance for the deferred tax asset and the accruals for potential liabilities. Actual results could differ from these estimates.
Stock Purchase Warrants	Stock Purchase Warrants   The Company accounts for warrants issued to purchase shares of its common stock as equity in accordance with FASB ASC 480, Accounting for Derivative Financial Instruments Indexed to, and Potentially Settled in, a Company’s Own Stock, Distinguishing Liabilities from Equity.
Fair Value of Financial Instruments	Fair Value of Financial Instruments   The Company determines the fair value of its assets and liabilities based on the exchange price in U.S. dollars that would be received for an asset or paid to transfer a liability (an exit price) in the principal or most advantageous market for the asset or liability in an orderly transaction between market participants on the measurement date. Valuation techniques used to measure fair value maximize the use of observable inputs and minimize the use of unobservable inputs. The Company uses a fair value hierarchy with three levels of inputs, of which the first two are considered observable and the last unobservable, to measure fair value:     ● Level 1 — Quoted prices in active markets for identical assets or liabilities.         ● Level 2 — Inputs, other than Level 1, that are observable, either directly or indirectly, such as quoted prices for similar assets or liabilities; quoted prices in markets that are not active; or other inputs that are observable or can be corroborated by observable market data for substantially the full term of the assets or liabilities.         ● Level 3 — Unobservable inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities.   The carrying amounts of financial instruments, such as cash, and accounts payable and accrued liabilities, approximate the related fair values due to the short-term maturities of these instruments. The carrying values of our notes payable approximate their fair values because interest rates on these obligations are based on prevailing market interest rates.
Derivative Financial Instruments	Derivative Financial Instruments   The Company evaluates its financial instruments to determine if such instruments are derivatives or contain features that qualify as embedded derivatives. For derivative financial instruments that are accounted for as liabilities, the derivative instrument is initially recorded at its fair value and is then re-valued at each reporting date, with changes in the fair value reported in the consolidated statements of operations. The classification of derivative instruments, including whether such instruments should be recorded as liabilities or as equity, is evaluated at the end of each reporting period. Derivative instrument liabilities are classified in the balance sheet as current or non-current based on whether or not the net-cash settlement of the derivative instrument could be required within twelve months of the balance sheet date. There were no derivative liabilities outstanding as of September 30, 2023 and December 31, 2022.
Income (Loss) per Common Share	Income (Loss) per Common Share   Basic net income (loss) per share is computed by using the weighted-average number of common shares outstanding during the period. Diluted net income (loss) per share is computed giving effect to all dilutive potential shares of Common Stock that were outstanding during the period. Diluted income (loss) per share reflects the potential dilution, using the treasury stock method, that could occur if securities or other contracts to issue common stock were exercised or converted into common stock or resulted in the issuance of common stock that is then shared in the income (loss) of the Company as if they had been converted at the beginning of the periods presented, or issuance date, if later. In computing diluted income (loss) per share, the treasury stock method assumes that outstanding options and warrants are exercised and the proceeds are used to purchase common stock at the average market price during the period. Options and warrants may have a dilutive effect under the treasury stock method only when the average market price of the common stock during the period exceeds the exercise price of the options and warrants. Dilutive potential shares of Common Stock consist of incremental shares of Common Stock issuable upon exercise of stock options. No dilutive potential shares of Common Stock were included in the computation of diluted net loss per share on September 30, 2023, because their impact would have been anti-dilutive.
Property and Equipment	Property and Equipment   Property and equipment are stated at cost or fair value if acquired as part of a business combination. Depreciation is computed by the straight-line method and is charged to operations over the estimated useful lives of the assets. The carrying amount and accumulated depreciation of assets sold or retired are removed from the accounts in the year of disposal and any resulting gain or loss is included in the results of operations. The estimated useful lives of property and equipment are as follows:   Schedule of property plant equipment estimated useful lives       Computers, software, and office equipment   3 years   Furniture and fixtures   7 years     As of September 30, 2023, the Company’s property was fully depreciated. Depreciation expense for the nine months ended September 30, 2023, and 2022, amounted to $9,134 and $19,725, respectively.
Goodwill and Intangible Assets	Goodwill and Intangible Assets   Goodwill represents the future economic benefit arising from other assets acquired that could not be individually identified and separately recognized. The goodwill arising from the Company’s acquisition is attributable to the value of the potential expanded market opportunity with new customers. Intangible assets have either an identifiable or indefinite useful life. Intangible assets with identifiable useful lives are amortized on a straight-line basis over their economic or legal life, whichever is shorter. The Company’s amortizable intangible assets consist primarily of customer relationships, trademarks, and product formulations. The useful life of these customer relationships is estimated to be three years.   Goodwill is not amortized but is subject to annual impairment testing unless circumstances dictate more frequent assessments. The Company performs an annual impairment assessment for goodwill during the fourth quarter of each year and more frequently whenever events or changes in circumstances indicate that the fair value of the asset may be less than the carrying amount. Goodwill impairment testing compares the fair value of the reporting unit to its carrying amount. The fair value of the reporting unit is determined by considering both the income approach and market approaches. The fair values calculated under the income approach and market approaches are weighted based on circumstances surrounding the reporting unit. Under the income approach, the Company determines fair value based on estimated future cash flows of the reporting unit, which are discounted to the present value using discount factors that consider the timing and risk of cash flows. For the discount rate, the Company relies on the capital asset pricing model approach, which includes an assessment of the risk-free interest rate, the rate of return from publicly traded stocks, the Company’s risk relative to the overall market, the Company’s size and industry and other Company-specific risks. Other significant assumptions used in the income approach include the terminal value, growth rates, future capital expenditures, and changes in future working capital requirements. The market approaches use key multiples from guideline businesses that are comparable and are traded on a public market. If the fair value of the reporting unit is greater than its carrying amount, there is no impairment. If the reporting unit’s carrying amount exceeds its fair value, then an impairment loss is recognized in an amount equal to the excess. As of December 31, 2022, the Company determined that its goodwill and intangibles were fully impaired, and as a result, recorded an impairment of goodwill and intangible assets amounting to $4,261,683 in its Statements Operations for the year ended December 31, 2022.
Recently Issued Accounting Pronouncements	Recently Issued Accounting Pronouncements   In June 2016, the Financial Accounting Standards Board (“FASB”) issued Accounting Standards Update (“ASU”) No. 2016-13, Financial Instruments—Credit Losses (Topic 326): Measurement of Credit Losses on Financial Instruments (“ASU 2016-13”) and also issued subsequent amendments to the initial guidance: ASU 2018-19, ASU 2019-04, and ASU 2019-05 (collectively, “Topic 326”). Topic 326 requires measurement and recognition of expected credit losses for financial assets held. The Company will be required to adopt this ASU for fiscal years beginning after December 15, 2022, including interim periods within those fiscal years. The adoption of Topic 326 is not expected to have a material effect on the Company’s condensed consolidated financial statements and financial statement disclosures.

v3.23.3

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Tables)	9 Months Ended
	Sep. 30, 2023
Accounting Policies [Abstract]
Schedule of property plant equipment estimated useful lives	Schedule of property plant equipment estimated useful lives       Computers, software, and office equipment   3 years   Furniture and fixtures   7 years

v3.23.3

PREPAID EXPENSE (Tables)	9 Months Ended
	Sep. 30, 2023
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Schedule of prepaid expense	Schedule of prepaid expense                     September 30, 2023     December 31, 2022   Matchbox Twenty (“MT”) agreement   $       $ 100,000   Deposit with joint venture partner             30,000   Total prepaid expenses   $       $ 130,000

v3.23.3

BUSINESS ACQUISITION (Tables)	9 Months Ended
	Sep. 30, 2023
Business Combination and Asset Acquisition [Abstract]
Schedule of fair value of consideration	Schedule of fair value of consideration         Common stock issued, 41,476,963 shares of the Company’s restricted common stock valued at $0.0101 per share   $ 418,917   Common stock issuable, 93,523,037 shares of the Company’s restricted common stock valued at $0.0101 per share     944,583   Net liabilities assumed     2,871,066   Cash paid     1,085,450   Fair value of total consideration paid   $ 5,320,016
Schedule of net asset acquired and liabilities assumed	Schedule of net asset acquired and liabilities assumed         Cash and cash equivalents   $ 107,689   Computer equipment     36,882   Total assets     144,571             Accounts payable and accrued liabilities     1,711,349   Notes payable     526,385   Deferred revenue     777,903   Total liabilities     3,015,637             Net liabilities assumed   $ 2,871,066
Schedule of net impairment	Schedule of net impairment         Goodwill impairment   $ 10,400,000   Intangible assets impairment     1,542,847   Reversal of Earnout liability     (7,679,984 ) Net impairment   $ 4,262,863

v3.23.3

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Tables)	9 Months Ended
	Sep. 30, 2023
Payables and Accruals [Abstract]
Schedule of accrued liabilities	Schedule of accrued liabilities                     September 30, 2023     December 31, 2022   Accounts payable and accrued expenses   $ 2,444,903     $ 2,389,231   Accrued interest     236,510       282,612   Soundstr Obligation     145,259       145,259   Total accounts payable and accrued liabilities   $ 2,826,672     $ 2,817,102

v3.23.3

CONVERTIBLE NOTES PAYABLE (Tables)	9 Months Ended
	Sep. 30, 2023
Debt Disclosure [Abstract]
Schedule of convertible notes payable	Schedule of convertible notes payable                     September 30, 2023     December 31, 2022   Various Convertible Notes(a)   $ 131,703     $ 131,703   Golock Capital, LLC Convertible Notes(b)     339,011       339,011   Total Convertible Notes   $ 470,714     $ 470,714       (a) This total is comprised of six convertible notes with five different noteholders. With the exception of one note for $28,500 due to a former related party which is interest free, all of the remaining notes at a 10% interest rate are past due their maturity. The Company has not received any default notices on these notes and continues to accrue interest on these notes. Additionally, $73,204 of these notes due to DBW Investments is in dispute. (b) On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Golock”) in the principal amount of $40,000 with an interest rate of 10% per annum and a maturity date of November 2, 2018. The note included an original issue discount of $5,000. The note is convertible into shares of the Company’s common stock at $0.015 per share. As additional consideration for Golock to enter into this agreement with the Company, the Company issued warrants to Golock to acquire in the aggregate 2,500,000 shares of the Company’s common stock at an exercise price of $0.015 per share that expire three years from the date of grant. The relative fair value of the warrants, the original issue discount, and the beneficial conversion feature totaling $40,000 was recorded as a debt discount and will be amortized to interest expense over the term of the note. On November 5, 2018, the Company amended the notes above by changing the conversion feature for the aggregate notes to be convertible into shares of common stock of the Company at the lower of (i) $0.015 per share or, (ii) 58% of the lowest closing bid price in the 20 trading days prior to the day that Golock requests conversion. This feature gave rise to a derivative liability of $553,000 at the date of issuance, as discussed below. The amendment also increased the principal face amount of notes to include accrued interest, and an additional $43,250 was added to the principal, which was recorded to financing costs. The aggregate balance of the notes outstanding, and the related debt discount was $302,067 and $0, respectively, as of December 31, 2018.

v3.23.3

STOCKHOLDERS’ DEFICIT (Tables)	9 Months Ended
	Sep. 30, 2023
Equity [Abstract]
Schedule of warrants	Schedule of warrants                     Number of Warrants     Weighted Average Exercise   Balance outstanding, December 31, 2020     23,805,027           Warrants expired or forfeited     (8,004,708 )     -   Balance outstanding and exercisable, December 31, 2021     15,800,319           Warrants exercised or forfeited     (15,800,319 )         Warrants granted during the year ended December 31, 2022     279,655,690           Balance outstanding and exercisable, December 31, 2022     279,655,690           Warrants exercised or forfeited     -           Warrants granted during the nine months ended September 30, 2023     -           Balance outstanding and exercisable, September 30, 2023     335,440,817         (a)      (a) The strike price on these warrants range between $0.01122 and $0.00264 and are subject to adjustment based on the market price of the Company’s stock price.

v3.23.3

ORGANIZATION AND BASIS OF PRESENTATION (Details Narrative) - USD ($)	1 Months Ended
	May 29, 2015	Feb. 13, 2023	Dec. 31, 2022	Feb. 14, 2022
Restructuring Cost and Reserve [Line Items]
Cash paid		$ 1,085,450
Initial shares issued			5,204,352	135,000,000
TGRI [Member]
Restructuring Cost and Reserve [Line Items]
Number of shares outstanding	50,762,987

v3.23.3

GOING CONCERN (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Cash on hand	$ 28,433		$ 82,807
Negative working capital	6,929,188
Accumulated deficit	38,151,090		$ 36,808,403
Net cash used in operating activities	$ 941,419	$ 749,643

v3.23.3

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Details)	9 Months Ended
	Sep. 30, 2023
Office Equipment [Member]
Property, Plant and Equipment [Line Items]
Preoperty and equipment useful life	3 years
Furniture and Fixtures [Member]
Property, Plant and Equipment [Line Items]
Preoperty and equipment useful life	7 years

v3.23.3

SIGNIFICANT AND CRITICAL ACCOUNTING POLICIES AND PRACTICES (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Accounting Policies [Abstract]
Deferred revenue	$ 714,613		$ 862,597
Derivative liabilities	0		$ 0
Depreciation expense	9,134	$ 19,725
Impairment of goodwill and intangible assets	$ 4,261,683

v3.23.3

PREPAID EXPENSE (Details)	Dec. 31, 2022 USD ($)
Deferred Costs, Capitalized, Prepaid, and Other Assets Disclosure [Abstract]
Matchbox Twenty (“MT”) agreement	$ 100,000
Deposit with joint venture partner	30,000
Total prepaid expenses	$ 130,000

v3.23.3

PREPAID EXPENSE (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2023	Dec. 31, 2022
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Prepaid expenses	$ (0)	$ 130,000
MT Agreement [Member]
Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items]
Description of payment	Company agreed to pay an advance of $100,000 against sales to MT and its affiliated companies, which was paid in full in installments, with the last installment of $40,000 paid on March 4, 2020.

v3.23.3

RELATED PARTY TRANSACTIONS (Details Narrative) - USD ($)	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Dec. 31, 2022
Related Party Transaction [Line Items]
Revenues from related party	$ 182,773	$ 9,579
License cost	$ 9,139	$ 479
Chief Executive Officers [Member]
Related Party Transaction [Line Items]
Advances from company			$ 10,000

v3.23.3

BUSINESS ACQUISITION (Details) - USD ($)	Feb. 13, 2023	Feb. 13, 2022
Business Acquisition [Line Items]
Cash paid	$ 1,085,450
VNUE Acquisition [Member]
Business Acquisition [Line Items]
Common stock issued, 41,476,963 shares of the Company’s restricted common stock valued at $0.0101 per share		$ 418,917
Common stock issuable, 93,523,037 shares of the Company’s restricted common stock valued at $0.0101 per share		944,583
Net liabilities assumed		2,871,066
Cash paid		1,085,450
Fair value of total consideration paid		$ 5,320,016

v3.23.3

BUSINESS ACQUISITION (Details 1) - VNUE Acquisition [Member]	Feb. 13, 2022 USD ($)
Business Acquisition [Line Items]
Cash and cash equivalents	$ 107,689
Computer equipment	36,882
Total assets	144,571
Accounts payable and accrued liabilities	1,711,349
Notes payable	526,385
Deferred revenue	777,903
Total liabilities	3,015,637
Net liabilities assumed	$ 2,871,066

v3.23.3

BUSINESS ACQUISITION (Details 2)	12 Months Ended
	Dec. 31, 2022 USD ($)
Business Combination and Asset Acquisition [Abstract]
Goodwill impairment	$ 10,400,000
Intangible assets impairment	1,542,847
Reversal of Earnout liability	(7,679,984)
Net impairment	$ 4,262,863

v3.23.3

BUSINESS ACQUISITION (Details Narrative) - USD ($)	1 Months Ended	12 Months Ended
	Feb. 14, 2022	Dec. 31, 2022	Feb. 13, 2022
Business Acquisition [Line Items]
Amortization of intangible assets		$ 758,333
Impairment of goodwill and intangible assets charge		$ 4,262,683
VNUE Acquisition [Member]
Business Acquisition [Line Items]
Number of shares acquisition	135,000,000
Fair value consideration paid to goodwill			$ 10,400,000
Fair value consideration paid to intangible assets			$ 2,600,000

v3.23.3

DEFERRED REVENUE (Details Narrative) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Revenue Recognition and Deferred Revenue [Abstract]
Deferred revenue	$ 714,613	$ 862,597

v3.23.3

ACCOUNTS PAYABLE AND ACCRUED LIABILITIES (Details) - USD ($)	Sep. 30, 2023	Dec. 31, 2022
Payables and Accruals [Abstract]
Accounts payable and accrued expenses	$ 2,444,903	$ 2,389,231
Accrued interest	236,510	282,612
Soundstr Obligation	145,259	145,259
Total accounts payable and accrued liabilities	$ 2,826,672	$ 2,817,102

v3.23.3

SHARES TO BE ISSUED (Details Narrative) - USD ($)	12 Months Ended
	Dec. 31, 2022	Sep. 30, 2023	Feb. 14, 2022
Shares To Be Issued
Common stock to be issued, value	$ 975,174	$ 975,174
Common stockshares to be issued	5,204,352		135,000,000
Common stock shares to be issued, value	$ 247,707
Number of shares issuable	72,026,422
Number of shares issuable, value	$ 727,647

v3.23.3

NOTES PAYABLE (Details Narrative) - USD ($)	3 Months Ended	9 Months Ended
	Sep. 30, 2023	Sep. 30, 2023	Dec. 31, 2022
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Notes payable	$ 1,329,865	$ 1,329,865	$ 1,134,262
Accruing interest		8.00%
Ylimit [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Notes payable	1,052,761	$ 1,052,761
Amount converted	$ 102,603
Maturity date	Sep. 30, 2024
Advances from company	$ 50,000	$ 50,000
Former Stage [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Notes payable			$ 277,104

v3.23.3

CONVERTIBLE NOTES PAYABLE (Details) - USD ($)		1 Months Ended	9 Months Ended
		Feb. 02, 2018	Sep. 30, 2023	Dec. 31, 2022	Dec. 31, 2018
Short-Term Debt [Line Items]
Convertible notes payable			$ 470,714	$ 470,714
Warrant issued to common stock			343,790,112
Various Convertible Notes [Member]
Short-Term Debt [Line Items]
Convertible notes payable	[1]		$ 131,703	131,703
Golock Capital, LLC Convertible Notes [Member]
Short-Term Debt [Line Items]
Convertible notes payable	[2]		$ 339,011	$ 339,011
Principal amount		$ 40,000
Interest rate		10.00%
Maturity date		Nov. 02, 2018
Conversion price		$ 0.015
Warrant issued to common stock		2,500,000
Exercise price		$ 0.015
Related debt discount		$ 40,000			$ 0
Increase/decrease in derivative liability		553,000
Financing cost		$ 43,250
Convertible notes payable					$ 302,067
[1] This total is comprised of six convertible notes with five different noteholders. With the exception of one note for $28,500 due to a former related party which is interest free, all of the remaining notes at a 10% interest rate are past due their maturity. The Company has not received any default notices on these notes and continues to accrue interest on these notes. Additionally, $73,204 of these notes due to DBW Investments is in dispute. [2] On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Golock”) in the principal amount of $40,000 with an interest rate of 10% per annum and a maturity date of November 2, 2018. The note included an original issue discount of $5,000. The note is convertible into shares of the Company’s common stock at $0.015 per share. As additional consideration for Golock to enter into this agreement with the Company, the Company issued warrants to Golock to acquire in the aggregate 2,500,000 shares of the Company’s common stock at an exercise price of $0.015 per share that expire three years from the date of grant. The relative fair value of the warrants, the original issue discount, and the beneficial conversion feature totaling $40,000 was recorded as a debt discount and will be amortized to interest expense over the term of the note. On November 5, 2018, the Company amended the notes above by changing the conversion feature for the aggregate notes to be convertible into shares of common stock of the Company at the lower of (i) $0.015 per share or, (ii) 58% of the lowest closing bid price in the 20 trading days prior to the day that Golock requests conversion. This feature gave rise to a derivative liability of $553,000 at the date of issuance, as discussed below. The amendment also increased the principal face amount of notes to include accrued interest, and an additional $43,250 was added to the principal, which was recorded to financing costs. The aggregate balance of the notes outstanding, and the related debt discount was $302,067 and $0, respectively, as of December 31, 2018.

v3.23.3

CONVERTIBLE NOTES PAYABLE (Details Narrative) - USD ($)		1 Months Ended	9 Months Ended	12 Months Ended
		Apr. 29, 2019	Sep. 30, 2023	Dec. 31, 2019	Dec. 31, 2022
Short-Term Debt [Line Items]
Convertible notes payable			$ 470,714		$ 470,714
Golock Capital, LLC Convertible Notes [Member]
Short-Term Debt [Line Items]
Convertible notes payable	[1]		339,011		$ 339,011
Debt instrument, principal amount			339,011
Amount of additional penalties and interest			$ 1,172,782
Amendment [Member] | Golock [Member]
Short-Term Debt [Line Items]
Debt instrument, description		They received (a) a warrant to purchase 12,833,333 shares of the Company’s common stock for 48 months, exercisable at a strike price of $.00475. The Company recorded a financing charge of $28,227 related to these warrants and (b) the conversion noted above was changed from 58% to 50% of the lowest closing bid price in the 20 trading days prior to that day that Golock requested conversion
Debt conversion, converted instrument, amount				$ 53,331
Debt conversion, converted instrument, accured interest				$ 23,102
Debt conversion, converted instrument, shares issued				100,000,000
Convertible notes payable				$ 339,010
Notes past due				$ 285,679
[1] On February 2, 2018, the Company issued a convertible note to Golock Capital, LLC (“Golock”) in the principal amount of $40,000 with an interest rate of 10% per annum and a maturity date of November 2, 2018. The note included an original issue discount of $5,000. The note is convertible into shares of the Company’s common stock at $0.015 per share. As additional consideration for Golock to enter into this agreement with the Company, the Company issued warrants to Golock to acquire in the aggregate 2,500,000 shares of the Company’s common stock at an exercise price of $0.015 per share that expire three years from the date of grant. The relative fair value of the warrants, the original issue discount, and the beneficial conversion feature totaling $40,000 was recorded as a debt discount and will be amortized to interest expense over the term of the note. On November 5, 2018, the Company amended the notes above by changing the conversion feature for the aggregate notes to be convertible into shares of common stock of the Company at the lower of (i) $0.015 per share or, (ii) 58% of the lowest closing bid price in the 20 trading days prior to the day that Golock requests conversion. This feature gave rise to a derivative liability of $553,000 at the date of issuance, as discussed below. The amendment also increased the principal face amount of notes to include accrued interest, and an additional $43,250 was added to the principal, which was recorded to financing costs. The aggregate balance of the notes outstanding, and the related debt discount was $302,067 and $0, respectively, as of December 31, 2018.

v3.23.3

STOCKHOLDERS' DEFICIT (Details) - $ / shares	9 Months Ended		12 Months Ended
	Sep. 30, 2023		Dec. 31, 2022	Dec. 31, 2021
Equity [Abstract]
Number of warrants, Begining Balance	279,655,690		15,800,319	23,805,027
Number of warrants, Warrants expired or forfeited			(15,800,319)	(8,004,708)
Weighted average exercise price, Warrants expired or forfeited
Warrants granted			279,655,690
Number of warrants, Warrants expired or forfeited			15,800,319	8,004,708
Number of warrants, Ending Balance	335,440,817	[1]	279,655,690	15,800,319
[1] The strike price on these warrants range between $0.01122 and $0.00264 and are subject to adjustment based on the market price of the Company’s stock price.

v3.23.3

STOCKHOLDERS’ DEFICIT (Details Narrative) - USD ($)	1 Months Ended		3 Months Ended		9 Months Ended
	May 25, 2022	Jul. 02, 2019	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Dec. 31, 2022	May 22, 2019
Class of Stock [Line Items]
Common stock, shares authorized			4,000,000,000		4,000,000,000	4,000,000,000
Common stock par value			$ 0.0001		$ 0.0001	$ 0.0001
Common stock, shares issued			2,077,292,582		2,077,292,582	1,676,014,753
Common stock, shares outstanding			2,077,292,582		2,077,292,582	1,676,014,753
Number of shares sold during the period					343,790,112
Number of value old during the period					$ 647,645
Common stock capitalized		2,000,000,000
Preferred stock capitalized		5,000,000
Weighted-average remaining contractual life					3 years 9 months
Non cash charge				$ 15,300,000
Board of Directors Chairman [Member]
Class of Stock [Line Items]
Preferred stock voting rights	These share which represented 3,000,000,000 (billion) votes, was valued at the trading price of the Company’s securities of $0.0051 on the date of Board of Director approval
Series A Convertible Preferred Stock [Member]
Class of Stock [Line Items]
Designated shares							4,126,776
Series A Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			20,000,000		20,000,000	20,000,000
Preferred stock, shares par value			$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock, shares issued			3,200,579		3,200,579	4,250,579
Preferred stock, shares outstanding			3,200,579		3,200,579	4,250,579
Shares converted			1,050,000
Series A Common Stock [Member]
Class of Stock [Line Items]
Shares converted			52,500,000
Series B Preferred Stock [Member]
Class of Stock [Line Items]
Preferred stock, shares authorized			2,500		2,500	2,500
Preferred stock, shares par value			$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock, shares issued			2,504		2,504	2,305
Preferred stock, shares outstanding			2,504		2,504	2,305
Proceeds from issuance of preferred stock					$ 164,000
Series B Preferred Stock [Member] | GHS Investments [Member]
Class of Stock [Line Items]
Shares issued for proceeds					199
Series C Preferred Stock [Member]
Class of Stock [Line Items]
Designated shares	10,000
Preferred stock, shares authorized			10,000		10,000	10,000
Preferred stock, shares par value			$ 0.0001		$ 0.0001	$ 0.0001
Preferred stock, shares issued			3,000		3,000	0
Preferred stock, shares outstanding			3,000		3,000	0
Preferred stock voting rights	The holders of the Series C Preferred Stock shall have the right to cast one million (1,000,000) votes for each share held of record on all matters submitted to a vote of holders of the Company’s common stock.
Preferred Stock Series C [Member]
Class of Stock [Line Items]
Shares outstanding			3,000		3,000	3,000

v3.23.3

SUBSEQUENT EVENTS (Details Narrative) - USD ($)	2 Months Ended	9 Months Ended
	Nov. 16, 2023	Sep. 30, 2023
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of common stock sold		343,790,112
One Director [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during the period for consulting services	80,000,000
Two Director [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during the period for consulting services	140,078,571
Two Consultants [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Stock issued during the period for consulting services	205,000,000
GHS [Member]
Collaborative Arrangement and Arrangement Other than Collaborative [Line Items]
Number of common stock sold	47,232,113
Proceeds from line of credit	$ 34,000

---